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ABSTRACT 
 
Objectives 
To determine the time to cessation of Ascaris suum egg shedding, the 
percent of animals that stop shedding, and to estimate the reduction in 
environmental burden from eggs shed in naturally infected female breeding 
swine after different treatment levels of fenbendazole to better determine timing 
of anthelmintic use prior to movement into a farrowing environment.  To 
determine the ovicidal activity of different fenbendazole levels on Ascaris suum 
eggs shed from naturally infected commercial breeding female swine. 
 
Materials and methods 
Study 1 – Egg shedding 
Five experiments across three commercial sow farms known to be 
infected with A suum were conducted. Breeding gilts and sows were identified 
with natural A suum infections and allocated to one of 4 treatments: CNT = 
untreated controls, TX1 = 545.5 mg fenbendazole for one day, TX2 = 545.5 mg 
fenbendazole daily, for 3 consecutive days (1636.5 mg total), and TX3 = 1636.5 
mg fenbendazole for one day (TX3 only in experiment 5). Fecal samples were 
collected on various days and evaluated using the modified Wisconsin sugar 
flotation technique, with at least 1 EPG considered a positive sample.  Time-to-
negative was evaluated using Kaplan-Meier survival analysis with Log-Rank test 
and censoring of animals that reached the end of the study period still shedding.  
x 
 
Percent negative at the end of the experiment was evaluated by Chi-square 
analysis using Fisher’s exact test.  Environmental burden (BURD), a calculation 
of eggs observed versus eggs expected, was evaluated by ANOVA and Tukey’s 
studentized test. 
 
Study 2 - Embryonation 
Three experiments were conducted on a commercial breeding farm 
infected with A suum.  Breeding gilts and sows were identified with natural A 
suum infections and allocated to one of 4 treatments: CNT = untreated controls, 
TX1 = 545.5 mg fenbendazole for one day, TX2 = 545.5 mg fenbendazole daily, 
for 3 consecutive days (1636.5 mg total), and TX3 = 1636.5 mg fenbendazole for 
one day (TX3 only in experiment 3).  Eggs were isolated from fecal samples at 
various days post-treatment (dpt) by experiment and incubated in 0.1 N H2SO4 at 
room temperature for 60 days.  Embryonation rates (ER) for each animal were 
determined by counting the number of eggs with fully developed larvae out of 
100 eggs counted. 
 
Results 
Study 1 – Egg shedding 
Mean time-to-negative shedding ranged from 9.3 to 13.1 for TX1, 8.9 to 
13.1 days and 9.8 for TX3 with 0 to 10 percent censored, while CNT ranged from 
13.4 to 28.2 with 70 to 100 percent censored.  For all fenbendazole treatment 
groups, 90 to 100 percent of sows were negative by the end of the study, 
xi 
 
compared to 0 to 28.6 percent for CNT.  Mean BURD range was 7.0 to 60.9 for 
TX1, 13.9 to 60.8 for TX2, 29.3 for TX3 and 60.4 to 219.0 for CNT.  All 
fenbendazole treatment values were different from CNT (P<0.05) but not from 
each other for time-to-negative, percent negative and BURD. 
 
Study 2 - Embryonation 
ER of A suum eggs shed from CNT animals ranged from 90.3 to 99.3 
percent across all experiments and sampling days.  ER were significantly 
(P<0.0001, ANOVA) reduced to 29.3 and 30.5 percent for TX1 and TX2 in A 
suum eggs shed at 8 dpt, and 26.6 percent for TX3 in eggs shed at 6 dpt.  
Differences in ER between treatments was only seen in eggs shed at 4 dpt; 
TX1=75.4, TX2=70.9, and TX3=47.0.  In addition, many of the A suum eggs shed 
from treated animals had atypical character, such as abnormal cell division, 
granular appearance and irregular shapes. 
 
Implications 
 Fenbendazole is an effective anthelmintic for the treatment of Ascaris 
suum in naturally infected breeding gilts and sows. 
 
 When using fenbendazole for the control of A suum transmission from 
dams to offspring, treatment should begin approximately 14 days prior to 
movement into clean farrowing facilities.   
 
xii 
 
 Fenbendazole was effective at all treatment levels used in decreasing the 
number of A suum eggs shed into the environment.  
 
 Fenbendazole is ovicidal against A suum in eggs shed from naturally 
infected breeding gilts and sows. 
 
 Use of fenbendazole provides additional epidemiological benefits in 
control of A suum through reduced effective environmental contamination 
due to the reduced number of eggs shed and those that develop to an 
infectious larvae. 
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 CHAPTER 1. OVERVIEW 
1.1 Statement of Problem 
The large roundworm of swine, Ascaris suum (A suum), is the most 
common internal parasite of swine and has worldwide distribution (Greve 2012).  
While the apparent prevalence and severity of infection has decreased in many 
modern swine production systems, likely due to improved sanitation and effective 
anthelmintics, the parasite is still prevalent in some farm types and production 
systems (Roepstorff 1994, Pittman 2010a, Pittman 2010b, Duff 2014).  The 
persistence of A suum is mainly due to the fecundity of the adult female (Kelley 
1956, Olsen 1958), the resistance of the A suum egg leading to persistence in 
the environment (Gaasenbeek 1998) and a direct life cycle with an extra-
intestinal migration phase that does not require an intermediate host (Roepstorff 
2003).  In addition, swine management systems that utilize known 
epidemiological risk factors will maintain A suum at a prevalence that could 
produce overt clinical disease and economically important performance losses 
(Roepstorff 1994, Yaeger 2009, Woods 2012). 
The main economic impacts of A suum infection are decreased feed 
efficiency and daily weight gain in growing pigs (Hale 1985, Stewart 1988), 
condemnation of “milk spot” livers at slaughter (De Bie 2003, McOrist 2008) and 
increased medication costs associated with treatment or prevention (Boes 2010, 
USDA 2007, 2008). 
The main goal of a parasite control program is to minimize the economical 
impacts of disease.  Since A suum eggs shed from hosts are not initially 
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infectious and require a period of time in the environment to develop, the main 
aspects of a control program are sanitation to remove eggs prior to embryonation 
to an infectious stage and use of an effective anthelmintic to reduce 
contamination of the environment.  Common control programs in swine breeding 
herds aim to stop the transmission from dam to piglets and the farrowing 
environment to piglets.  This is accomplished through improved sanitation of the 
farrowing facilities, washing of the sow prior to movement into those facilities, 
and treatment of sows with an effective anthelmintic prior to farrowing to 
eliminate or reduce worm and fecal egg burden (Raffensperger 1927, Behlow 
1978, Biehl 1987, Roepstorff 1998).  It is important that the anthelmintic utilized 
results in either significant reductions or complete cessation of egg shedding to 
minimize contamination of the farrowing environment and subsequent 
transmission to offspring.  Accordingly, it is important to know how long after 
treatment that cessation of egg shedding occurs to properly time the treatment 
prior to movement into clean farrowing facilities.  If the treatment interval is too 
close to movement, then contamination of the farrowing environment will occur.  
This is emphasized by the common misconception that one can simply treat 
sows at the time of loading farrowing or that treatment can be as soon at 2 days 
prior to loading (Brad Thacker, personal communication; Jeremy Pittman, 
personal observation).   
The available literature with A suum and fenbendazole only report a few 
time points post-treatment and does not clearly characterize the time required to 
reach cessation of egg shedding.  These reports are usually conducted in 
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experimental challenge settings with exact dosing of fenbendazole which may 
not extrapolate to natural infections under commercial management and 
treatment conditions.  Limited data is available for the “decay curve” of fecal egg 
counts in naturally infected sows that are given treatments in a manner 
consistent with on-farm practices, which usually either approximates the weight 
of the animal or are based on a convenience fixed dose (i.e., number of scoops) 
for all animals regardless of size (Dangolla 1996; Jeremy Pittman, personal 
observation).  In addition, some producers may utilize fenbendazole in a manner 
inconsistent with the label, such as giving a single day treatment as compared to 
the labeled 3 day treatment.  Much of the experimental fenbendazole literature 
supports the efficacy of single dose programs with fenbendazole for A suum, 
however there is no reported data available for the evaluation of these lower 
single doses under commercial conditions and with naturally infected sows. 
The purpose of the research contained in this thesis was to characterize 
the egg shedding pattern and embryonation rates of A suum eggs shed in 
naturally infected sows using common on-farm treatment and dosing methods 
with fenbendazole (Safe-Guard EZ Scoop, Merck Animal Health, Summit, New 
Jersey). 
 
1.2 Thesis Organization 
This thesis is organized into five main chapters and one appendix chapter, 
including this overview chapter with a statement of the problem that led to the 
research contained herein.   
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The second chapter is a literature review of Ascaris suum and 
fenbendazole use in swine.  It is imperative that when studying or developing 
health strategies for a parasite one must understand the parasite (e.g., life cycle, 
characteristics) and the epidemiological factors associated with prevalence and 
transmission, in order to develop effective programs to reduce disease and 
production impacts. There are references to the human roundworm, Ascaris 
lumbricoides, for several reasons. First, for a long time these two closely related 
but distinct species were considered to be the same parasite, and in fact the 
swine roundworm has been cited as Ascaris lumbricoides var suum in the early 
literature (Seamster 1950, Rogers 1956) and a search of PubMed returns 
manuscript titles using this nomenclature up to 1992 
(http://www.ncbi.nlm.nih.gov/pubmed/; accessed 07 November 2014).  Second, 
A suum and A lumbricoides research is complementary and interchangeable in 
the literature stream responsible for describing life cycles and characteristics.  
Third, A suum infection in pigs and in pig populations has been used consistently 
as a model to understand A lumbricoides worm burdens, disease dynamics, 
transmission, treatment and control in human populations (Boes 1998, Dold 
2011).  Lastly, A suum and A lumbricoides can infect their respective non-host 
species, with A suum frequently infecting humans and A lumbricoides having 
been found in pigs (Anderson 1995, Nejsum 2012, Zhou 2012). 
As well as understanding the parasite, an integral part of parasite control 
in livestock populations is the use of an effective anthelmintic at strategic times 
based on an understanding of the target parasite’s life cycle and relative to the 
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host’s production cycle and husbandry management.  Therefore a review of 
fenbendazole has been included in order to provide background on the drug’s 
efficacy, therapeutic range, safety and mechanisms of action.  The literature 
review focuses on fenbendazole’s documented efficacy against the various life 
stages of A suum, and specifically how it relates to reduction in fecal egg 
shedding and ovicidal activity which are the basis for the experiments presented 
in Chapters 3 and 4.  In addition, the literature review cites papers that describe 
other benzimidazole class anthelmintics and their effects on other parasites of 
several host species, to further support the hypotheses, methodologies and 
conclusions included in this thesis. 
Chapter 3 is a manuscript that was submitted to the Journal of Swine 
Health and Production, the principle journal for practicing swine veterinarians in 
the United States and Canada, and is formatted according to the guidelines for 
publication, with the exception of reference citations.  The manuscript describes 
the egg shedding pattern of A suum following treatment with various levels of 
fenbendazole in naturally infected breeding gilts and sows in five studies 
conducted on three large commercial breeding farms.  The goals of this series of 
five experiments were to characterize the time to cessation of shedding and the 
percentage of animals that stop shedding A suum eggs, and to estimate the 
relative reduction in environmental contamination, using different levels of 
fenbendazole.  Data presented in this manuscript can be used by veterinarians to 
make better recommendations to producers on when to apply treatment to sows, 
and theoretically other ages of swine (e.g., replacement gilts, feeder pigs), prior 
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to moving to clean facilities in an attempt to control environmental contamination 
and transmission. 
Chapter 4 is a companion manuscript to Chapter 3 and was submitted to 
the Journal of Swine Health and Production and formatted according the 
guidelines, with the exception of reference citation.  The goal of the three 
experiments included in this manuscript was to evaluate and confirm the ovicidal 
activity of fenbendazole by determining the embryonation rate of A suum eggs 
excreted in the feces of naturally infected gilts and sows at 0 to 8 days post-
treatment, the main shedding period of A suum eggs post-treatment with 
fenbendazole (Chapter 3).  The data presented in this manuscript demonstrates 
the added epidemiological advantage of using fenbendazole as a treatment for A 
suum. 
The editors of the Journal of Swine Health and Production requested that 
the two companion manuscripts be combined into a single manuscript, thus 
publication was pursued with those recommendations and revisions (pending at 
the writing of this thesis).  It was decided however, that the original manuscripts 
would be kept intact in Chapters 3 and 4 in this thesis to demonstrate 
extensiveness and completeness of each study and allow for more detailed 
discussion that was required to be edited out of the combined manuscript. 
Components of Chapters 3 and 4 have previously been presented as oral 
presentations at the 4th European Symposium of Porcine Health Management in 
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Bruges, Belgium (Pittman 2012) and the 23rd International Pig Veterinary Society 
Congress in Cancun, Mexico (Pittman 2014a,b). 
Chapter 5, a general conclusions chapter, is included in order to tie the 
results of the two manuscripts in Chapters 3 and 4 together, as one is an 
extension of the other.  Animals in the experiments included in Chapter 4 are a 
subset of animals from the experiments in Chapter 3.  Fenbendazole initially 
reduces worm burden and fecal egg count, but it also serves to reduce the 
percentage of those eggs that actually develop to an infectious egg in the 
environment due to its ovicidal activity, therefore impacting the “next step” of the 
life cycle and another critical control point. 
Finally, Chapter 6 is an appendix detailing the procedures used in the 
experiments included within this thesis, in the event that others are interested in 
repeating or continuing this type of work.  It was important to include the 
protocols as they are adaptations and modifications of previously reported 
methods. 
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 CHAPTER 2. LITERATURE REVIEW 
2.1  Ascaris suum 
In 1906, in the book Diseases of Swine, author Dr. Robert A. Craig said of 
the swine roundworm; “Many stockmen have erroneous ideas regarding this 
parasite.” (Craig 1906)  Since then we have learned much about the life cycle 
and control of Ascaris suum, however one still encounters stockmen and 
veterinarians with insufficient understanding of the most common and 
cosmopolitan parasite of swine.  In addition, several veterinary colleges within 
the United States, including those in the main swine producing areas, place little 
emphasis on swine parasites in current curriculums due to a misconception that 
parasites are no longer a concern in modern swine production systems (Jeremy 
Pittman, personal communication). 
 
2.1.1 Life cycle and worm characteristics 
The life cycle of A suum is direct and very similar to other Ascarids and 
has been studied extensively as a model for Ascaris lumbricoides the human 
Roundworm.  Pigs ingest eggs containing an infective L3 larvae from a 
contaminated environment.  If the ingested eggs are unembryonated non-
infective they will pass through the intestine and out in feces undamaged and 
resume embryonation in the environment (Marti 1986, Boes 1997).  The eggs 
begin to hatch in the stomach and small intestine in response to the acidic pH, 
bile enzymes and peristalsis (Geenen 1999).  The liberated L3 larvae penetrate 
the mucosa of the cecum and proximal spiral colon as early as 3 hours post 
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ingestion (hpi), but the majority between 6 and 12 hpi (Rhodes 1977, Murrell 
1997).  Larvae penetrate the mucosa and migrate toward the liver via the hepatic 
portal system.  The majority of larvae can be found in the liver between 8 and 18 
hpi, where migration results in mechanical damage leading to a hypersensitivity 
reaction with eosinophilic inflammation (Murrell 1997).  The inflammation results 
in fibrosis and development of “milk spots”.  The larvae leave the liver via the 
caudal vena cava, travel through the heart and to the pulmonary artery and 
capillaries (Murrell 1997). Migration through the lungs occurs 4 to 6 days post 
ingestion (dpi) and results in pulmonary damage, leading to rapid expiratory 
efforts (“thumps”) and coughing.  The larvae penetrate the alveoli and migrate up 
the bronchial tree to the trachea then the pharynx where the larvae are coughed 
up and swallowed around 8 to 10 dpi.  The L3 larvae then go through two more 
molts in the small intestine, to an L4 larvae around 10 dpi and an L5 larvae 
around 23 to 24 dpi, and develop to a mature adult (Roepstorff 2003).  When 
larvae reach the small intestine there is a mass expulsion of many of the larvae, 
especially with larger infectious doses, which is considered to be related to an 
immune mechanism or self-population control (Jorgensen 1975, Boes 1998).  
Adults live in the small intestinal lumen and feed on ingesta.  Adult females begin 
to produce fertilized unembryonated eggs 6 to 8 weeks post ingestion of 
embryonated eggs (wpi) if mature males are present.  It is interesting to note that 
migration is not required, as experimental intravenous injection, which bypasses 
the liver, of in vitro hatched L3 result in patent intestinal infections (Jungersen 
1999). 
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Adult A suum are relatively large with females 40 to 45 cm in length and 
males smaller at 25 cm.  The adult female A suum has been estimated to 
produce between 1 and 2 million eggs per day (Kelley 1956, Olsen 1958).  By 
comparison the average daily egg output of A lumbricoides has been estimated 
to be around 240,000 (Brown 1927, Sinniah 1982).   The female A suum can also 
produce fertile eggs for 2 weeks after removal of adult males (Jungersen 1997).  
The majority of adults are expelled by 23 wpi, however some may live for more 
than a year (Olsen 1958).  There is a poor relationship between fecal egg counts 
and the number of female worms (Bindseil 1974).  It is important to note the 
concept of population overdispersion which has been demonstrated in A suum 
and A lumbricoides, in which a small number of hosts harbor the majority of the 
worm burden in a population while a large percentage of the population may not 
be infected (Boes 1998). 
 
2.1.2 Egg development and resistance 
Eggs shed from hosts are not initially infectious, and must go through a 
period of development in the environment.  This is a key aspect to the Ascarid life 
cycle that is often unrecognized, however is “central in the epidemiology of the 
parasite” and control programs, allowing time to remove either the eggs (i.e., 
sanitation) or the susceptible hosts (i.e., early weaning) from the contaminated 
environment (Roepstorff 2003).  Successful embryonation is highly dependent on 
optimal temperature, humidity and oxygen tension (Seamster 1950, Arene 1986, 
Gaasenbeek 1998, Brown 1928).   
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Under ideal conditions the larvae of A suum develop from a 1-cell embryo 
(day 0) to a 2-cell (d2), 3- to 4-cell (d3), early morula (d4), late morula (d6), 
blastula (d7), gastrula (d8), pre-larvae (d10), L1 (d12) and L2 (d16) (Cruz 2012).  
A final molt to an L3 occurs in about twice the time it takes to develop to the L2, 
depending on temperature, at which time they are infectious (Roepstorff 2003).  
Seamster determined the development and rate of A suum eggs in a temperature 
range from 8.89 to 37.8ºC (Seamster 1950).  No cleavage was seen at 
temperatures 11.1ºC and lower (Seamster 1950). Motile embryos were seen in 
ranges between 16.7 and 34.4ºC, however there was a decline in the percent of 
motile embryos at 32.2ºC and higher, and at 37.8ºC all ova died (Seamster 
1950).  Seamster determined that optimum development temperature was at 
31.1ºC (Seamster 1950).   Work by Arene (1986) confirmed the increasing rate of 
development with increased temperatures, and found maximum rate of 
development at 31ºC .  However, eggs that were embryonated at 28ºC and 
higher had reduced hatching rate, longevity post hatch and reduced infectivity 
(Arene 1986).  Arene suggested that optimal embryonation occurred at 22ºC 
(Arene 1986) with respect to percent embryonation and percent infectivity.   
Egg development in practical environmental settings has been evaluated.  
Connan described the development of A suum eggs under simulated conditions 
in a pig house in Great Britain in which eggs were placed periodically over 20 
months between January 1973 and September 1974 (Connan 1977).  Eggs 
which were started January to May, or after September developed slowly or not 
at all until June or July when ambient temperature rose above an apparent 
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development threshold.  Eggs started in June and July developed more rapidly 
and became infectious in August and September.  In addition, eggs observed 
during the months of October and April did not show any additional development 
during this period, indicating an arrested state (Connan 1977).  Stevenson 
demonstrated similar developmental periods between June 1976 and December 
1977 in eggs placed in an unheated swine facility (Stevenson 1979), also in 
Great Britain.  Eggs did not develop between the months of November and May 
when maximum daily ambient temperatures were below the development 
threshold of 14.5ºC as described by Seamster, however rapid development was 
seen in the months of June, July and August when maximum temperatures were 
above 14.5ºC (Stevenson 1979, Seamster 1950).  A similar study was also 
conducted in Saskatchewan, Canada by Wagner and Polley, in which eggs were 
placed at monthly intervals from July 1997 to July 1998 (Wagner 1999).  
Development was most rapid during the summer months of June, July and 
August, however in contrast to the work by Connan and Stevenson egg 
development never ceased, but rather slowed during the spring, fall and winter 
months (Wagner 1999).  Wagner attributed this continued development to a 
higher ambient temperature within the barns that rarely dropped below the 
development threshold of 14.5ºC, as compared to the studies conducted in Great 
Britain (Wagner 1999).  Stevenson also noted in his work that development of 
eggs in the environment of pigs could be influenced by supplemental heating, 
and even consideration of increased ambient temperatures from the body heat 
generated from pigs in the environment (Stevenson 1979).  Interestingly in all 
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three papers the authors reference the seasonality seen in “milk spots” at the 
abattoirs as reported by others (Connan 1977, Stevenson 1979, Goodall 1991, 
Menzies 1994, Lundehein 2010, Sanchez-Vazquez 2012), in which a consistent 
increase is seen in pigs marketed during the late summer and early fall and 
subsequent decrease seen in winter and spring.  This seasonality is likely related 
to the timing of marketing growing pigs previously exposed to fully developed 
larvae in the late spring and summer environments. 
Ascarid eggs have been called “one of the most resistant biological 
structures” (Wharton 1980).  Eggs are highly resistant to chemicals and 
environmental influences, due to their complex shell which is composed of 4 
layers (Foor 1967).  The layers include, from the inside-out; an ascaroside lipid 
layer responsible for the impermeability to many chemicals, a thick chitinous 
layer which provides structural strength, a thin vitelline layer and an outer “sticky” 
proteinaceous uterine layer (Roepstorff 2003).  Due to the resistance of A suum 
eggs, they are commonly used to test potential disinfection chemicals and as an 
indicator organism in chemical treatment process protocols for human 
wastewater treatment facilities (EPA 1994, Pecson 2005).  In one study, the eggs 
of A suum were resistant to eleven disinfectants, many of which are commonly 
used in swine facilities, such as phenol, sodium hydroxide, quaternary 
ammonium and glutaraldehyde based products (vd Burg 1987).  Resistance to 
povidone-iodine has also been reported (Labare 2013).  This resistance to many 
environmental and chemical influences contributes to the consistent challenges 
with A suum and inability to easily remove the pathogen from the environment.  
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2.1.3 Environmental epidemiology related to sow to piglet transmission 
The main economic impacts of A suum are those that occur in the growing 
pig, therefore much of the focus and control efforts are at reducing the clinical 
impact of disease in this population.  With the development of age-segregated 
and early weaning production operations, controlling disease transmission 
between the breeding herd and grow-finish population became easier due to a 
physical separation of infected and susceptible populations (Harris 2000).  While 
not specifically referenced as a pathogen controlled by these types of operations 
in Harris’s Multi-Site Pig Production, there is a significant advantage for the 
control A suum.  The important and common control strategy for A suum in 
modern swine production takes advantage of the fact that eggs shed from hosts 
are not initially infectious, and therefore allow for a period where targeted 
measures can significantly minimize or eliminate the transmission risk from sow 
to piglet.  In many modern swine operations, sows are moved from a breeding 
location to individual farrowing stalls where piglets can be farrowed into a 
sanitary environment and sows can be managed individually.  Piglets are then 
weaned to an off-site location at a young age (2 to 4 weeks), and prior to the 
required development period of A suum eggs, shed from their dam.  In these 
management styles farrowing rooms or barns are commonly managed with “All-
In/All-Out” style of pig flow in which the room is completely emptied and sanitized 
prior to loading the next group of due-to-farrow sows, which minimizes the 
transmission of disease from previous groups to subsequent farrowing sows and 
litters.  This management style can minimize or prevent the transmission of A 
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suum from breeding herd to growing herd.  Under most standard cleaning 
protocols (including high pressure washing, use of detergents and disinfectants, 
and allowing a period for surfaces to dry) the farrowing facility should be a low 
risk for A suum transmission to piglets from previous contamination.  Therefore 
the main risk of transmission would be from the current birth dam or possibly a 
surrogate dam shedding eggs.  It is important to note that due to the period of 
development required outside the host, eggs shed into the farrowing environment 
from sows are not usually directly infectious to her offspring if weaning occurs at 
an age younger than the period required for the eggs to development infectious 
larvae.  This is supported by work that shows poor correlation between a sow 
farm and grow-finish A suum infection status when wean age is less than 5 
weeks, however when wean age is 6 weeks or greater, grow-finish animals are 
twice as likely to be positive if originating from a positive sow farm (Roepstorff 
1991, Homgren 1998).  While this age segregation has an inherent 
epidemiological advantage in reducing the transmission from dam to piglet, there 
are still transmission risks associated with lateral transmission to piglets from 
unsanitary farrowing environments (“hot spots” from previously housed sows) or 
fomites from other areas of the farm (Nilsson 1982).  Therefore, overall 
sanitation, management and biosecurity of the entire herd are also important 
control measures for A suum. 
Another common recommendation (referenced in the McLean County and 
North Carolina Swine Parasite Control programs) on sow farms for control of 
parasites is to thoroughly wash sows with soap prior to loading into farrowing, in 
19 
 
order to remove contaminated fecal material from the skin and underlining 
(Raffensperger 1927, Behlow 1978, Biehl 1987).  While this recommendation and 
mode of transmission makes logical sense, it is likely only a significant concern 
when sows are housed in a highly contaminated areas and are excessively dirty 
(Thomas 1983).  De Deken et al demonstrated a decreased association of 
finishing ascariasis when sourcing sow farms washed sows and used 
anthelmintics prior to farrowing (De Deken 1984).  Mercy et al identified a lower 
prevalence in growing pigs from sow herds that routinely washed sows prior to 
farrowing (Mercy 1989).  Johnson et al demonstrated that using anthelmintic 
alone did not reduce the correlation between sow farm status and finishing 
status, but that control of gestation contamination in the sow herd was associated 
with reduced incidence of finishing ascariasis (Johnson 2003).  While proper 
timing and use of effective anthelmintic treatment of breeding females can be an 
important component of an A suum control program, reduction of the 
environmental parasite burden, namely through sanitation and proper 
management of animals and their environment, remain the most fundamental 
measures in control of A suum in swine herds and farms. 
 
2.1.4 Prevalence 
The apparent prevalence and severity of A suum has decreased in many 
modern swine operations, as has the prevalence of many other swine parasites.  
Theoretically the main reasons for the reduced prevalence are the improved 
sanitation of modern facilities, which routinely remove a large amount of the 
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feces from the environment (e.g., slatted flooring), use of All-In/All-Out 
management which helps to break transmission from older pigs to newly placed 
pigs and allows better sanitation between groups, separation of age groups to 
different off-site facilities, namely off-site weaning of young piglets (<4 weeks of 
age) (e.g. two and three-site production, early and isowean systems), and the 
strategic use of highly effective anthelmintics.  It should be noted here that while 
not important for A suum, due to a direct life cycle, another cause of reduced 
parasite burden in modern swine production has been the removal of 
intermediate hosts (e.g. earthworms, beetles) by moving pigs indoors.  However, 
even with the above advancements in modern swine production, A suum can still 
be found in modern swine production facilities. 
Prevalence in the United States is not well understood as A suum is no 
longer considered a significant swine disease.  In addition, liver condemnations 
at slaughter which serves as a metric for ascarid prevalence are no longer 
measured at major abattoirs in the US (Meisinger 2004).  Current published 
estimates of A suum prevalence are restricted to the 2006 National Animal 
Health Monitoring System (NAHMS) surveys conducted by the United States 
Department of Agriculture (USDA), a 2012 survey questionnaire conducted by 
Elanco Animal Health (Greenfield, Indiana) and a few production system level 
cross-sectional surveys of breeding and grow-finish sites.  In the 2006 NAHMS 
survey, 26.8 percent of breeding sites indicated that disease problems were 
attributed to “roundworms”, however only 9.7 percent of these sites had this 
confirmed by a veterinarian or a laboratory (USDA 2007b).  In nursery age pigs, 
21 
 
15.8 percent of sites indicated “roundworms” as a disease issue with only 13.4 
percent of those sites diagnosed by a veterinarian or laboratory (USDA 2007b).  
In grow-finish sites, 15.5 percent of sites indicated “roundworms” as a disease 
issue, with only 23.1 percent of those sites having the parasite diagnosed by a 
veterinarian or laboratory (USDA 2007b).  The 2012 USDA NAHMS report for 
small-enterprise swine operations indicated that 8.2 percent of all breeding 
operations identified roundworms as a cause of disease in gilts or sows and in 
8.6 percent of weaned pigs (USDA 2014).  In the Elanco Animal Health’s “Full-
Value Pigs” survey, 16.6 percent of those surveyed identified “worms/parasites” 
as causing disease, however this does not clarify A suum from other potential 
parasites (e.g. Trichuris suis, Sarcobtes scabiei, etc.) (Pelger 2012d).  In 2002 
and 2003, 141 lots across 7 abattoirs were surveyed in the United States and 
Canada for evidence of mange and roundworms, 25 percent of the lots had at 
least one animal with “milk spots” (Melancon 2005).  In a 2010 survey of a large 
swine production system located in North Carolina and Virginia, 25 percent (10 of 
40 sites) of breeding herds representing 12,000 breeding sows and 38.5 percent 
(35 of 91 sites) of grow-finish sites representing 370,000 finishing spaces were 
positive for A suum (Pittman 2010 a,b).  A 2014 survey of a production system 
located in eastern North Carolina, looking at 58 sites with breeding age animals, 
reported a 23 herd percent prevalence of A suum (Duff 2014). 
Prevalence of A suum is better documented in other countries, and is 
generally considered more of a concern than in the United States.  In the same 
“Full Value Pigs” survey conducted by Elanco Animal Health, parasites were 
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considered a health challenge in 25.6, 17.2, and 7.8 percent of surveys from 
Europe, Asia and Latin America respectively (Pelger 2012b,c,d).   
A Canadian survey in 2002 indicated that 21.8 percent of 64 farms tested 
were positive for A suum, even though 95.7 percent of the producers used some 
type of anthelmintic in their sow herds (Young 2002).  Previously in two abattoir 
surveys in Saskatchewan, Canada, 44 percent of 2,500 market animals had 
some form of liver scaring with 8 percent being severely affected in the first 
survey, and 17 percent had adult ascarids in the intestine with 50 percent of 
livers with lesions in the second survey.  Out of the total 611 farms surveyed, 477 
had pigs with affected livers (Wagner 1997).  A similar set of Saskatchewan 
surveys in 1980 demonstrated 37 percent of animals with adult ascarids and 46 
percent with “white spots” in 2,500 market animals observed and in a second 
study, 44 percent of 2,500 market animals had white spots indicating not much 
change in prevalence in this region over two decades (Polley 1980). 
Prevalence of A suum in the European Union (EU) is better understood.  
In a 2003 review article by De Bie, incidence rates in EU countries were noted as 
25 percent of 7,690 livers in France, 47.5 percent of 6,250 livers in Austria, 10.7 
percent of 15 million livers in The Netherlands, 50 percent of lots from 9,000 
livers in the United Kingdom, 35 percent of pigs in Belgium showed some form of 
liver pathology and in Germany, 4.3 to 53.6 percent of livers from farms 
demonstrated white spots (De Bie 2003).  Sanchez-Vazquez et al looked at milk 
spot rates in 12 abattoirs in England between 2005 and 2010 and reported a 4.2 
percent rate in milk spots on 34,168 pigs (Sanchez-Vasquez 2012).  In Scotland, 
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5.2 to 5.3 percent of livers evaluated over a two year period from 45,000 
carcasses from 150 herds representing 75 percent of Scottish pig production 
demonstrated milk spots (Strachan 2006).  Menzies et al demonstrated an 
increase in mean annual prevalence of milk spots in Ireland from 4 to 9 percent 
from 1969 to 1991, demonstrating an increase with modernization of swine 
production (Menzies 1994).  A similar study, conducted in Ireland in 2012 and 
2013 evaluating 12,597 finishing pigs at slaughter facilities, demonstrated an 
average percent of pigs with milk spots within batch to be 11.5 percent (Hidalgo 
2014).  In addition, the prevalence within batch was greater than 10 percent in 
42.8 percent of batches (Hidalgo 2014).  In a 2002-2003 survey of Brittany, 
France abattoirs 10 to 65 percent of pigs within batches demonstrated milk spots 
(Kanora 2004).  In Belgium, 11.1 percent of livers were condemned from 152,364 
pigs over a three and a half year period from 56 farms (Vyt 2004). In Sweden, a 
survey of the six largest abattoirs demonstrated a rate of 2.5 to 6.5 percent milk 
spots in 729 herds (Lundeheim 2010).  In Slovakia, 19,017 animals from 279 
herds were inspected from 2000 to 2009 and a decrease in milk spot rates was 
seen from 39.5 to 6.9 percent (Ondrejková 2012).  The authors attributed this 
decline to an increasing positive attitude toward parasite control within the 
Slovakian swine industry.  In the Czech Republic, between 2003 and 2005, 9,163 
livers from 99 farms had a range of 7.1 to 11 percent with milk spots by lot 
(Žižlavský 2006).  A survey in Italy from January to October 2012 evaluated 
4,764 batches of slaughter pigs totaling 667,028 pigs and reported an overall 
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milk spot prevalence of 13.9 percent, a batch prevalence of 17.1 percent and a 
within batch prevalence range of 8 to 100 percent (Luppi 2014). 
In a study between 1986 and 1988, 516 herds located within the Nordic 
countries (Demark, Sweden, Finland, Norway and including Iceland) were 
surveyed by fecal analysis.  Prevalence rates in sows ranged from 1.4 to 13.4 
percent, while gilt prevalence was generally higher at 3.8 to 27.2 percent 
(Roepstorff 1998).  Prevalence rates in finishers ranged from 5 to 34.5 percent 
(Roepstorff 1998). 
Ascaris suum prevalence has also been documented in Asian counties.  A 
survey between 1984 and 1986 in Singapore evaluated almost 3 million pigs and 
reported 4.3 percent had liver lesions, of which 20.4 percent of those were 
condemned (Tiong 1989).  In Japan, between 2005 and 2007, a survey of 150 
farms across Japan reported a 2 percent prevalence by fecal analysis, with 
prevalence being higher in sows than fattening pigs (Kobayashi 2009). In Osaka, 
Japan, a survey of feces of 129 pigs from an abattoir reported 14.7 percent 
positive for A suum (Matsubayashi 2009).  In China, a 2007 to 2009 survey 
reported A suum as the most common parasite in swine, with 20.25 percent of 
intensive managed sow farms positive and 20.42 percent of extensively 
managed sow herds positive (Lai 2011). 
As the prevalence and severity of A suum has generally decreased with 
modern swine production and facilities, there still exist swine production 
operations in which particular risk factors are unavoidable, namely organic, niche 
market or outdoor operations (Roepstorff 2011).  In many countries, legislation or 
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customer demand is forcing change in the management of swine to “improve 
welfare” that in many ways promotes increased transmission of parasites.  In 
Denmark, such legislation is represented by the requirement to loose house 
sows in groups, provide access to rooting material (straw, bedding, etc.), solid 
flooring, sprinklers that increase humidity and restrictions on medication use 
(Roepstorff 2011).  In the US, regulations are very similar for USDA defined 
“organic” operations (http://www.ams.usda.gov/AMSv1.0/organicinfo).  In the EU, 
Council Directives 2001/88/EC and 2001/93/EC 
(http://ec.europa.eu/food/animal/welfare/farm/pigs_en.htm) set minimum 
standards for the provisions of pigs, including several requirements that will 
potentially increase parasite transmission. 
Prevalence of A suum infection is generally higher in the above types 
(organic, extensive, welfare-friendly) of operations.  Pattison et al demonstrated a 
higher prevalence in sows housed on pasture as compared to stalled or tethered 
sows (Pattison 1980).  Interestingly these authors also described a lack of 
influence of anthelmintics on pasture sows as compared to a positive influence in 
indoor housed sows (Pattison 1980).  Eriksen et al described a higher prevalence 
in outdoor herds and small indoor herds as compared to larger indoor herds, 
particularly in the growing populations (Eriksen 1996).  In a study on Danish 
organic herds, Cartensen et al described a higher prevalence of A suum in these 
herds as compared to conventional herds, particularly in weaners and fatteners, 
and indicated the regulations of organic herds (e.g., straw bedding, access to 
roughage, no prophylactic anthelmintics, extended withdrawal periods and 
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weaning at 7 weeks of age) as increased risk factors (Cartensen 2002).  In this 
study, A suum were found in 14 percent of soil samples from the pastures and in 
35 percent of the slaughter pigs (Cartensen 2002).  Eijck and Borgsteede 
surveyed free-range, organic and conventional pig farms in The Netherlands and 
found a prevalence of 50, 73.7 and 11.1 percent, respectively in each type of 
operation (Eijck 2005).  In a survey of 26 niche market herds in the Midwest US, 
Yaeger et al reported 15.8, 29.4 and 61.9 percent of fecal samples from sows, 
nursery and finisher were positive for A suum which was determined to be a 
higher prevalence than conventional herds (Yaeger 2009).  It was also noted that 
many of these niche herds commonly used anthelmintics, but appropriately did 
not achieve successful parasite control. 
Prevalence within farm or within a flow of pigs is usually dependent on age 
of the animals, with older growing pigs having a higher prevalence than younger 
pigs and breeding sows (Roepstorff 1998).  Gilts and younger parity females 
have a higher prevalence than older sows, likely due to development of immunity 
over time (Marti 1986, Urban 1989, Roepstorff 1998, Nosal 2008). 
 
2.1.5 Production and economic impact 
The main production and economic impacts of A suum infection are 
reduced feed conversion (FC), reduced average daily gain (ADG), liver 
condemnations from milk spots and costs associated with routine anthelmintic 
treatment and prevention measures (Greve 2012).  In general, the level of impact 
on swine can be related to the level of infectious dose, and thus worm burden of 
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the individual animal.  However when the impact is assessed at a population 
level, the impact is not generally appreciated, likely due to overdispersion of the 
parasite burden or the overriding influence of more significant diseases (Hale 
1985, Bernardo 1990, Boes 2010).  In the case of overdispersion, only a small 
percentage of the population have the parasite burden, thus the impact on 
performance of this small percentage could easily be masked by the 
performance of the majority parasite-free population.  However, it is possible that 
those animals with the higher parasite burden are likely to represent lower value 
pigs within the population, such as cull or light weight market pigs. 
The adult A suum lives within the small intestinal tract and consumes 
nutrients from the lumen of the gut, therefore reducing feed efficiency and 
conversion.  In addition, larval migration through the intestinal mucosa and major 
organs of the body have a negative impact on feed utilization and growth.  
Zimmerman et al, when studying the effect of the anthelmintic pyrantel on A 
suum in growing pigs, demonstrated an improvement in FC by 11 percent in 
treated pigs as compared to infected control pigs, but only in groups fed a low 
protein diet, not in groups fed a high protein diet fed groups (Zimmerman 1971).  
Nilsson and Martinsson described a significantly reduced growth rate of 37 
grams per day in pigs when fecal egg counts were greater than 10,000 (Nilsson 
1980).  In the commonly cited work done by Hale et al, pigs were given three 
levels of infectious dose of A suum eggs (600, 6,000 or 60,000 eggs) to 
determine the production impact of infection.  The authors reported a linear and 
quadratic trend in reducing final weight and ADG with increasing infectious dose 
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(Hale 1985).  Pigs were 5, 7 and 13 percent less efficient than controls when 
challenged with 600, 6,000 or 60,000 eggs, respectively (Hale 1985).  When 
evaluating the efficacy of fenbendazole, Stewart et al demonstrated a 15 to 22 
percent improved FC in pigs treated 2 to 4 days post-infection (dpi) than control 
pigs or pigs treated later (6 to 8 dpi), demonstrating that early migration phases 
have a significant impact on feed conversion (Stewart 1984).  In this study, ADG 
was 23 percent greater than infected controls, regardless of timing of treatment 
(Stewart 1984).  In work by Bernardo et al the number of ascarids at slaughter 
did not have a significant impact on ADG, but “lifetime burden”, an estimated 
measure of magnitude and duration of fecal egg counts, was significantly 
associated with ADG (Bernardo 1990).  In the same study the authors indicated 
that while ascarid infection was detrimental to ADG, only a maximum of 1 percent 
change in ADG should be expected if parasite control was initiated in heavily 
infected farms (Bernardo 1990). 
In a meta-analysis of endoparasites, Kipper reported pigs with 
endoparasites had a 5 percent lower daily feed intake, 31 percent lower ADG 
and 6 percent lower total weight gain than control animals (Kipper 2011).  Control 
animals also demonstrated a 17 percent improved FC ratio (Kipper 2011).  
Kipper modeled a 4 percent increase in time to a fixed target market weight in 
pigs with endoparasites, but it must be noted that there was no discrimination as 
to the type of endoparasite (A suum, T suis, etc.) in this work (Kipper 2011). 
The migration of larvae through the liver and resultant “milk spot” 
pathology is arguably the largest and most appreciated economic impact of A 
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suum in swine.  Livers with severe scarring are condemned or down-graded 
since they cannot be sold for human consumption.  Livers are high in several 
vitamins and minerals and are either considered delicacies or are a staple of low-
income population diets, depending on the country (Marti 2011).  In North 
America, the economic impact is generally not experienced by the producer since 
payment is based on carcass dressed weight, which does not include the liver 
and other organs, therefore lost opportunity is experienced by the processor 
(Hurnik 1995).  However, in other countries, a penalty may be imposed on a 
producer, such as in The Netherlands where a 1 € penalty per pig with a “white 
spot” liver was applied to a producer to incent better parasite control on the farm 
(van Wagenberg 2010).  McOrist et al calculated the loss of liver condemnations 
to be 0.30 to 0.50 € kg-1 ($0.18 to 0.31 lb-1) in 2007 in the EU.  In a survey of 
seven packers in the United States, Meisinger reported the lost value of 
condemned livers to be $0.27 lb-1 to $0.30 per animal (Meisinger 2004).  In this 
same survey 3 of 6 packers reported that domestic and export markets 
influenced the value of livers.  Liver values can vary depending on the domestic 
demand and packer access to export markets.  At the time of this writing (May 
2014) the US domestic value of livers was $24.00 cwt-1 for edible livers, $13.50 
cwt-1 for inedible livers (used in pet food) and $9.00 cwt-1 for rendered product 
(personal communication, Charles Allison, Smithfield Packing, Smithfield, 
Virginia).  The export market within the US has seen an increase in edible pork 
offal, of which liver is a major contributing organ (Marti 2011).  In 2012, edible 
byproduct (variety meats) accounted for 13.7 percent of the total value of US 
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exports with more than 90 percent of these products exported (Herlihy 2013).  
The edible byproducts account for 6 percent of the total value of a pig (Marti 
2011).  To compare the value of livers domestically to an export market, the 
average value of livers in the US in 2010 was $16.73 cwt-1, while the average 
price in China was $51.80 cwt-1 (Marti 2011).  As export market demand 
increases, the value of unblemished livers will increase, and could return focus to 
A suum control by the producer. 
The cost of routine anthelmintics for control or treatment can be significant 
to swine operations, especially if not required or extensively used (Roepstorff 
1997).  In the 2006 NAHMS survey in the US, 74.7 to 76.8 percent of sites 
actively dewormed sows and 64 to 68.2 percent dewormed boars as part of their 
routine herd health protocols (USDA 2007a, USDA 2008).  It is important to note 
that use of anthelmintic was the most common disease prevention practice used 
in these herds; even more than antibiotic usage in the feed, water or as an 
injection.  In addition to breeding animals, 30 to 47.2 percent of sites dewormed 
piglets prior to weaning, 33.4 to 37.1 percent dewormed nursery pigs and 30.6 to 
34.0 percent dewormed grow-finish pigs (USDA 2007a, USDA 2008).  The 
average US prices of a single 400 lb sow treatment for the available 
anthelmintics at the time of this thesis were $2.46 for fenbendazole (Safe-Guard, 
Merck Animal Health, Summit, NJ), $0.52 for pyrantel tartrate (Banminth, Phibro 
Animal Health, Teaneck, NJ), $1.55 for ivermectin (Ivomec, Merial LTD, Duluth, 
GA) and $0.50 for piperazine (Wazine, Fleming Laboratories, Inc, Charlotte, NC) 
(Prices from QC Supply available at http://www.qcsupply.com/; accessed 01 May 
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2014, Banmith price provided by Phibro Animal Health).  While not available at 
the time of this writing, the cost to treat a 400 lb sow with dichlorvos was $0.67 
(Atgard C, price provided by Boehringer Ingelheim Vetmedica, Inc, St Joseph, 
MO).  Using the above calculations and assuming 10 pigs weaned per sow 
farrowed, the cost of treating weekly batches of sows can be $0.05-0.25 per 
weaned pig. 
Stewart and Hale utilized the literature available at the time in the US to 
estimate a production impact (growth and feed conversion only) from A suum of 
$86.7 million to the 1988 US swine industry, representing an average of $4.02 
(range $2.36-6.38) per market animal (Stewart 1988).  The assumptions made 
for this calculation were a 91 day feeding period with a start weight of 26.6 kg, a 
105.4 kg end weight, daily gains of 0.87 kg, 3.03 feed to gain ratio and a total 
cost of feed of $42.02 (Stewart 1988).  It is important to note that today, the 
assumptions made by Stewart and Hale are not valid, as the US swine industry is 
significantly different from 1988 with changes in management, facility design, 
genetics, nutrition, input costs, market value and A suum prevalence; however no 
recent research has been done to characterize the performance impact of A 
suum on production.  Table 2.1 shows current estimated economic impact of A 
suum in grow-finish pigs as $13.36 for each infected animal, based on current 
feed prices and market value (Iowa State University Extension, Ames, IA), 
national average pig performance metrics (Agri Stats, Inc, Fort Wayne, IN) and 
using performance deficiencies as reported by Stewart and Hale (Stewart 1988). 
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It must be noted that, much of the early work on the economic impact of A 
suum was done with experimental infections and the reduced performance 
extrapolated to entire populations, which may not be a fair representation of the 
true economic impact of the disease in swine populations.  Urban et al could only 
demonstrate a significant impact in ADG in infected pigs on pasture, but not 
when groups were housed on concrete (Urban 1989).  Boes et al failed to 
demonstrate significant differences in final weight, ADG, FC or lean meat 
percentage in naturally infected pigs treated with flubendazole as compared to 
untreated controls (Boes 2010).  The authors indicated that other pathogens, 
such as Lawsonia intracellularis, have more of an association with performance 
metrics than does natural A suum infection (Boes 2010).  Bernardo et al in their 
modeling work indicated that there was more benefit in controlling respiratory 
disease in growing pigs than in parasite control (Bernardo 1990).  Further work 
must be done to fully understand the overall production and economic impact on 
populations and to justify the expense of prevention, control and treatment 
measures. 
Other potential impacts of A suum infection are an increase in secondary 
diseases, decrease in vaccine efficacy, reduced nutrient utilization, reduction in 
carcass quality, decreased sow performance and losses attributed to acute 
morbidity and mortality with acute infection.  These impacts while documented in 
the literature are generally less appreciated or not fully understood.   
The mechanical damage created by the migration of larvae through the 
intestinal mucosa, liver and lungs allows for the enhancement of secondary 
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pathogens to cause disease.  For example, a decreased rate of clearance of 
bacteria from the lung of weanling pigs infected with A suum has been reported 
(Curtis 1987).  Another aspect of A suum resulting in increased secondary 
bacterial pneumonia is a decreased phagocytic activity of macrophages in pigs 
infected with A suum (Urban 2007). 
Co-infection of A suum and Escherichia coli resulted in a synergistic 
pneumonia and systemic disease in piglets (Adedeji 1989).  Matusyavichus et al 
co-infected pigs with A suum and Erysipelothrix insidiosa [rhusiopathaie] which 
resulted in 80 to 100 percent mortality as compared to no mortality in groups 
infected with either pathogen alone (Matusyavichus 1985).  In mice infection 
models, co-infection with A suum and Pasteurella multocida resulted in a more 
severe pneumonia, septicemia and greater mortality than individual infections 
(Tjørnehøj 1992).  Smith et al suggested a significant association between A 
suum and Salmonella sp. in slaughter animals (Smith 2011).  Engle and Bush 
demonstrated a significant association of porcine circovirus Type 2 associated 
disease with a history of ascaris and hypothesized that immune stimulation 
resulting from larval migration could have been the mechanism for pigs to 
develop to the severe clinical form (Post Weaning Multisystemic Wasting 
Syndrome) of disease (Engle 2006).  In an early study of impact of A suum on 
hog cholera (Classical Swine Fever), Shope demonstrated that co-infection 
resulted in a more acute, severe and prolonged systemic disease and A suum 
exacerbated latent infections of hog cholera (Shope 1958). Underdahl and Kelley 
demonstrated ten times greater pulmonary consolidation in pigs exposed to 
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“virus pneumonia of pigs” [Mycoplasma hyopneumoniae] if exposed after 
ingestion of A suum eggs (Underdahl 1957).  Nayak and Kelley inoculated pigs 
with swine influenza virus (SIV) 8 days after inoculation with A suum eggs which 
resulted in 90 percent mortality and a more pronounced dyspnea as compared to 
30 and zero percent mortality for SIV and A suum alone exposed groups, 
respectively (Nayak 1965).  The authors suggested the more severe disease and 
synergism may only be significant during the migratory phase of A suum 
(approximately 8 to 10 days post-ingestion).   
In a case where feeder pigs were placed in highly contaminated outdoor 
pens, secondary pneumonia with Actinomyces pyogenes and P multocida 
occurred three weeks after a spike in larval associated respiratory disease, which 
resulted in 25 percent morbidity and 10 percent mortality (Perry 1993).  Post 
mortem evaluation revealed severe, diffuse pulmonary edema, multifocal 
pulmonary hemorrhage and severe parasitic hepatitis (Perry 1993).  
Microscopically a severe acute, eosinophilic and granulomatous interstitial 
pneumonia was seen (Perry 1993).  In another case, Gjestvang et al described 
acute respiratory distress and mortality in feeder pigs due to heavily 
contaminated (320 to 1240 EPG) sawdust bedding (Gjestvang 2004).  Pigs 
began to show signs of lethargy and pneumonia 5 days after arrival, and on day 
9 after arrival, 26 of 40 pigs had died from pneumonia due to larval migration 
(Gjestvang 2004).  A case report from Mexico in 2014 described acute and 
severe respiratory distress and 10 percent mortality in 23 week old finishing pigs 
(Trujano 2014).  At necropsy a significant number of migrating larvae were 
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visualized throughout the pigs’ airways and intestinal tract (Trujano 2014).  These 
cases highlight the potential for significant acute mortality when naïve pigs are 
exposed to heavily contaminated facilities.   
A suum has been loosely associated with gastric ulceration in pigs.  
Gastric ulceration has been reproduced experimentally in pigs exposed to A 
suum (Gaafar 1972), however the clinical significance and prevalence is not well 
appreciated.  In a case of acute exposure and disease of 3 month old pigs, 
gastric ulceration was seen in addition to coughing, dyspnea and fever (Qureshi 
1978).  The authors suggested the ulceration was due to an immunological 
mechanism or simply the off-feed event associated with the disease.  
Esophagogastric ulcers were weakly associated with A suum in a study 
conducted by Häni et al, but the authors concluded that the association was not 
biologically significant in the field (Häni, 1979). 
Infection with A suum has been shown to decrease the pig’s response to 
vaccine and reduced vaccine efficacy.  Steenhard et al demonstrated a reduced 
and delayed seroconversion to M hyopneumoniae vaccination when pigs were 
consistently exposed to infective A suum eggs before and during the vaccination 
period (Steenhard 2009).  When pigs were subsequently challenged with M 
hyopneumoniae, those exposed to A suum had a higher mean percentage of 
lung pathology compared to vaccinated only pigs.  The authors suggested that A 
suum interferes with vaccine efficacy through an immune modulatory effect, 
namely through a Th-2 skewed response (Steenhard 2009). 
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In addition to synergistic effects related to mechanical damage and 
immunomodulatory effects, A suum infection has a negative impact on nutrient 
utilization by the pig.  In experimentally challenged 15 day old pigs, Stephenson 
et al demonstrated histological changes of the tunica muscularis, intestinal villi, 
goblet cells and an infiltration of the lamina propria, and hypothesized that this 
damage could result in decreased nutrient uptake, especially in marginal protein 
diets (Stephenson 1980).  Martin et al described marked changes to the mucosal 
surface and intestinal villi at 58 days post-infection with A suum in pigs on low 
protein diets and suggested an association between the lesions and lactose 
maldigestion which is commonly seen in human ascariasis (Martin 1984).  
Forsum et al studied the impact of A suum on pigs fed protein deficient diets and 
demonstrated that reduced growth rates were seen after worms matured to 
adults and eggs were seen in the feces (Forsum 1981).  They described reduced 
fat digestion, reduced nitrogen retention and a lower lactase activity, resulting in 
infected pigs using protein less efficiently (Forsum 1981).  The impact was more 
significant in pigs on protein deficient diets, however similar trends were 
observed in pigs fed normal protein level diets (Forsum 1981).  Hale et al 
demonstrated a lower dry matter, crude protein and gross energy digestive 
coefficient in A suum infected pigs between 33 and 37 days post inoculation as 
compared to control pigs (Hale 1985).  Higher nitrogen retention was also seen in 
control pigs as compared to infected pigs (Hale 1985).  In humans, ascariasis 
can cause vitamin A deficiency if there is a marginal intake of vitamin A and 
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associated precursors, but this has not been demonstrated in pigs (Mahalanabis 
1976). 
Reduced nutrient utilization and reduced growth performance can also 
have an impact on carcass quality in swine.  In a study by Knecht et al, the 
meatiness of swine carcasses were compared between infected and uninfected 
pigs, and determined to be significantly different with a negative correlation to 
fecal EPG counts (Knecht 2011).  In a follow-up study by Knecht et al, carcasses 
from infected finishing pigs were statistically more likely to fall into carcass 
meatiness categories with less than 55 percent lean meat (Knecht 2012).  It is 
important to note that these studies looked at intestinal parasites in general and 
did not specifically correlate to A suum infection alone. 
While the impact of A suum on growth parameters and feed utilization in 
growing pigs has been documented, to the author’s knowledge there are very 
few published assessments of the impact of ascariasis on sow production 
metrics.  Danielson et al compared sow and litter performance in breeding 
females treated 7 to 10 days prior to farrowing with fenbendazole to untreated 
controls and demonstrated a significant reduction in average daily feed intake 
during lactation and an increased number of pigs weaned from treated sows as 
compared to untreated controls (Danielson 1991).  Hagsten et al summarized 
three studies that looked at sow productivity measures in internal parasite 
positive sows that either received anthelmintics (dichlorvos or fenbendazole) just 
prior to farrowing or were left untreated.  In each study there were numerical 
improvements and trends of significance (P<0.10) in sow average daily feed 
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intake, litter size and weight gain of the litters (Hagsten 1994).  The paper did not 
clarify which internal parasites were present in the sows, so the relationship to A 
suum could not be determined. 
Pattison et al studied the impact of another intestinal parasite of swine, 
Oesophagostumum dentatum, on sows and showed a significant 24.4 kg 
difference in body weight from service to weaning of infected groups compared to 
uninfected controls (Pattison 1979).  Infected sows weighed 10.5 percent less at 
weaning, consumed 29 percent more feed during lactation and had lower 
carcass backfat as compared to uninfected sows (Pattison 1979).  Uninfected 
sows averaged 12.8 total pigs born (TB) and 11.3 pigs born alive (BA) while 
infected sows averaged 12.4 TB and 9.5 BA (Pattison 1979).  While this does not 
characterize with certainty the potential impact of A suum on sows, it does 
demonstrate the potential negative impact of parasitism on sows and justifies that 
further work should be considered to better understand the impact of ascariasis 
on sow performance. 
 
2.1.6 Zoonosis and infection in other species 
Ascaris lumbricoides, the human roundworm, has an almost identical life 
cycle and epidemiology to A suum (Dold 2011).  The two parasites are 
morphologically indistinguishable from each other and much of the literature and 
research is used interchangeably (Dold 2011).  For a long time these two species 
were considered to be the same with the only variation being which host it was 
found in, such that some literature references A suum as Ascaris lumbricoides 
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var suum (Seamster 1950, Rogers 1956).  While the two species are currently 
considered distinct, they differ genetically by only a small amount (Dold 2011).  
Zoonotic infection can occur and is relatively common in some areas of the 
world.  It has been suggested that pig derived human ascariasis is more 
prevalent in developed and developing countries, where human ascariasis is 
better controlled due to sanitation, while underdeveloped countries where 
sanitation is poor have a higher endemic prevalence of human derived ascariasis 
(Nejsum 2005, Nejsum 2012). 
Molecular comparison of a ribosomal RNA internal transcribed spacer 
region (rRNA ITS-1) of nine North American human ascariasis cases indicated 
that A suum, and not A lumbricoides, was the causative parasite (Anderson 
1995).  In Maine, between 2010 and 2013, 14 cases of Ascariasis were 
documented from people on farms that raised organic produce and livestock 
(Colby 2013).  In a Washington state survey in 1981-1982, 18 of 23 cases of 
human Ascariasis had exposure to pigs, pig manure or sites where pigs were 
previously raised (Shoemaker-Nawas 1982).  In New Hampshire, five cases of 
human Ascariasis all reported exposure to pigs or soil contaminated with pig 
feces (Lord 1982).  In the United Kingdom, Bendall et al described significant 
associations between cases of human Ascariasis and living near pigs, with a 
significant odds ratio of 4.65 for having pigs in the same postcode (Bendall 
2011).  In Denmark, pigs were identified as the source of 27 cases of human 
ascariasis, 80 percent of which had known exposure to pig manure (Nejsum 
2005).  In Japan, comparison of the rRNA ITS-1 region in human ascariasis 
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cases and ascarids collected from swine slaughterhouses indicated that 
ascariasis is changing from human to human transmission to pig to human 
transmission (Arizono 2010).  A case of eosinophilic pneumonia, possibly due to 
A suum migrating larvae, was described in a 62 year old man who consumed raw 
pork liver (Izumikawa 2011).  In a survey of human and swine ascariasis in 
China, 19 of 20 human infections were determined to be direct from pigs (Zhou 
2012).  The study also described one case of swine ascariasis caused by A 
lumbricoides, demonstrating the potential of complete cross-infection (Zhou 
2012). The study estimated that 16.5 percent of all Chinese human ascariasis 
cases are derived from pigs, and suggested that the main reason for the high 
rate is due to the common practice of using human and pig manure as fertilizer in 
underdeveloped endemic areas (Zhou 2012).  The use of human and pig manure 
has been indicated as a risk factor for zoonotic transmission of Ascaris sp. 
(Kutsumi 1969, Arfaa 1984, Ziemer 2010) 
A suum is periodically diagnosed in other species, namely lambs, calves 
and cattle as a pneumonia due to larval migration, but does not establish as a 
patent infection (McCraw 1971, McLennan 1974, Gunn 1980).  It is also 
interesting to note that a sustained infection of pig derived A suum has been 
described in a population of chimpanzees at the Copenhagen Zoo in Denmark 
(Nejsum 2010). 
It is important to note that A lumbricoides is a significant parasitic disease 
in many underdeveloped areas of the world with global prevalence estimated at 
800 million people, and is considered one of the top neglected tropical diseases 
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(Hotez 2009).  Therefore continued understanding of the epidemiology and 
control methods for Ascaris sp. and using A suum in swine as a model for A 
lumbricoides in humans is valuable.   
 
 
 
4
2
 
 
2.1.7 Tables 
 
Table 2.1 Estimated economic impact of A suum on grow-finish pigs using current input costs and production values. 
 
121 days feedinga 
ADG 
(lbs) 
Feed 
Gain 
Ratio 
Total 
Feed 
Costc ($) 
Feed Cost 
Difference 
($) 
Market 
Valued ($/cwt, 
live weight) 
Market 
Value 
difference 
($/hd) 
Total 
Opportunity 
Loss ($/hd) 
Start 
Weightb 
(lbs) 
End 
Weight 
(lbs) 
Infected 58.5 264e 1.69e 2.92e 190.44 +$3.44 163.68 -$9.92 $13.36 
Control 58.5 280f 1.82f 2.66f 187.00 --- 173.60 --- --- 
a Model assumes a fixed-time system using the performance of the control group 
b Used same initial start weight reported by Stewart and Hale, 1988 
c Feed cost estimated at $0.32/lb, Iowa State University Extension and Outreach (available at: 
http://www.econ.iastate.edu/estimated-returns, accessed 05 May 2014) 
d Market value estimated at $62.00/cwt live weight, Iowa State University Extension and Outreach (available at: 
http://www.econ.iastate.edu/estimated-returns, accessed 05 May 2014) 
e Calculated using decreased performance metrics (as a percentage) of “all infected groups” from Stewart and Hale, 
1988 
f Agri Stats, Inc, Fort Wayne, IN, accessed 05 May 2014. 
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2.2 Fenbendazole 
2.2.1 Benzimidazole class, fenbendazole and current formulations 
Chemical structure 
The first benzimidazole (BZ), thiabendazole (TBZ), was discovered in 
1961 and began an exploration into other variations (Brown 1961).  The basic 
chemical structure of the BZ class is a methyl 5-substituted benzimidazol-2-yl-
carbamate.  Fenbendazole [methyl 5-(phenyl-thio)-2-benzimidazole-carbamate] 
has a substitution of a sulfide structure at the C5 carbon of the benzene ring 
(Baeder 1974) (Table 2.2).  The reversible metabolite of fenbendazole is its 
sulphoxide derivative, oxfendazole (also an effective anthelmintic) which then 
undergoes further and irreversible metabolism to fenbendazole sulphone (not 
effective as an anthelmintic) (McKellar 1990, Corwin 1977). (Table 2.2)  
 
Safety 
The benzimidazole class is ideal because at low doses it provides a broad 
spectrum of activity against helminths of many host species, has a high level of 
efficacy against many helminth species, and has a high margin of safety for 
mammals.  The LD50 in mice is very high at 10,000 mg·kg-1·, and single oral 
doses greater than 5,000 mg·kg-1 in swine were well tolerated (Düwel 1977).  
Fenbendazole does produce a transient leukopenia and increased sorbitol 
dehydrogenase levels in swine after 2,000 mg·kg-1 daily for 14 days or with 75 
and 125 mg·kg-1 for 5 days, compared to the labeled 9 mg·kg-1 dose (Hayes 
1979).  Morgan studied the effects of oxfendazole, one of the metabolites of 
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fenbendazole, on pregnant sows and found no observed toxic or teratogenic 
effects in pregnant sows dosed at 4.5 and 13.5 mg·kg-1 at repeated times during 
early pregnancy (Morgan 1982). 
 
Formulations 
Benzimidazoles are insoluble in water and thus all formulations are enteral 
in the form of a feed additive, paste or suspension (McKellar 1990).  In the United 
States, fenbendazole is currently available for swine in the form of a 20 percent 
Type A Medicated Article (Safe-Guard Dewormer 10 percent), a 1.8 percent 
Type B feed medication that is also labeled for feed top-dress (Safe-Guard EZ 
Scoop), and a 0.5 percent pellet feed top-dress (Safe-Guard Medicated 
Dewormer) (North American Compendium available at: 
http://swinemeds.naccvp.com; accessed 14 May 2014).  All products are 
currently manufactured and sold by Merck Animal Health (Summit, New Jersey).  
Fenbendazole is also currently available for swine in the European Union as a 
200 mg·mL-1 oral suspension for use in water delivery systems (Panacur 
Aquasol, MSD Animal Health, division of Merck Animal Health, Summit, New 
Jersey). 
 
Other relevant benzimidazoles 
Examples of other common BZ class anthelmintics used in human and 
veterinary medicine, and referenced within this thesis are; thiabendazole, 
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albendazole, mebendazole, oxfendazole and flubendazole (Egerton 1961, 
Wagner 1974, Bradley 1983, Boes 1998, Alvarez 2013). 
 
2.2.2 Pharmacokinetics and pharmacodynamics 
The benzimidazoles are considered to have the same efficacy and mode 
of action, but differ in their effectiveness due to solubility, absorption and 
distribution in the host and parasite (McKellar 1990).  The more soluble 
metabolite oxfendazole has a higher plasma concentration, than the less soluble 
fenbendazole.  In pigs, 44-50 percent of oral fenbendazole is excreted 
unchanged in the feces and 0.1 percent in the urine (Düwel 1977).  Both 
metabolites can be found in urine and feces (Düwel 1977).  Petersen and Friis 
demonstrated a bioavailability of 27.1 percent in orally administered 
fenbendazole in pigs (Petersen 2000).  The pharmacokinetics of fenbendazole 
was determined after a single oral administration of 5 mg·kg-1 (Petersen 2000).  
Parameter means (±SD) for fenbendazole and its metabolites, oxfendazole and 
fenbendazole sulfone, were evaluated and are summarized in Table 2.3.  
Metabolism and excretion of fenbendazole in pigs is rapid and occurs by 
microsomal oxidation within the liver (Szprengier-Juszkiewicz 2002).  The rapid 
metabolism and excretion of fenbendazole is supported by its small percent of 
the total AUC, low Cmax and low Tmax, compared to the metabolites.  Half-life of 
fenbendazole is approximately 8.3 hours (Petersen 2000).  In a study where 12 
pigs were fed 5 mg·kg-1 fenbendazole in feed for five days, the metabolite 
fenbendazole sulfone was evaluated at 24, 48 and 72 hours post completion of 
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treatment.  Liver, muscle, kidney and fat tissue residue levels were demonstrated 
to be below established maximum residue levels (MRLs) by 48 hours post 
treatment in muscle, kidney and fat and by 72 hours in liver, and thus the authors 
suggested that a 3 day withdrawal after completion of treatment would be 
sufficient (Capece 1999).  Further plasma (n=8) and tissue (n=12) 
pharmacokinetic studies in pigs with a single 5 mg·kg-1 oral dose found 
fenbendazole only in plasma at 2 hours with a mean concentration of 0.015 
ug·mL-1.  Metabolite levels reached a mean maximum concentration of 0.116 ± 
0.029 ug·mL-1 in plasma at 8 hours and were below the limit of detection by 60 
hours post treatment (Szprengier-Juszkiewicz 2002).  Fenbendazole could not be 
detected in kidney, liver or muscle tissue and only low concentrations of 
metabolites, below the currently established MRLs (500 ug·kg-1 for liver and 50 
ug·kg-1 for muscle, kidney and fat), could be found in liver tissue at 4 days after 
treatment.  The authors supported a 3 day withdrawal period (Szprengier-
Juszkiewicz 2002).  Plasma pharmacokinetics of the sum of fenbendazole 
metabolites from this study can also be found in Table 2.2. 
The rapid metabolism and excretion of fenbendazole permits a labeled 
zero day pre-slaughter withdrawal period in the United States.  However, the 
MRL’s for many foreign markets to the US require a 21 day pre-slaughter 
withdrawal from swine (US Pork Board MRL Database, available at: 
http://www.pork.org/Resources/214/MaximumResidueLimits.aspx, accessed 14 
May 2014), which according to the work done by Capece and Szprengier-
Juszkiewicz et al is excessive (Capece 1999, Szprengier-Juszkiewicz 2002). 
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2.2.3 Mechanism of action 
The mechanism of action of benzimidazole anthelmintics is not completely 
understood, however the main aspect involves the disruption of tubulin formation 
in both adult helminths and developing embryos (Friedman 1980, Lacey 1990, 
McKellar 1990).  Specifically, fenbendazole interacts with embryonic tubulin at a 
colchicine binding domain on the leading edge of tubulin polymerization, and 
prevents the formation of microtubules (Friedman 1980, Lacey 1987, Martin 
1997).  Microtubules are important for cell structure, proper cleavage, 
chromosome movement during cell division and embryogenesis (Martin 1997).  
Due to the interference with microtubules, eggs exposed to benzimidazole 
anthelmintics, both in vivo and in vitro, often have irregular shapes, atypical 
blastomeres and unequal divisions which result in arrested and irreversible 
development (Boes 1998, Düwel 1977, Egerton 1969, Kirsh 1982).  Tubulin is a 
relatively conserved protein across species, and while there is affinity of 
benzimidazoles to mammalian tubulin, studies have shown that with the low 
doses used therapeutically, the affinity of benizmidazoles to helminth tubulin is 
250-500 times higher than that of mammalian tubulin, allowing for the high range 
of safety of the benzimidazoles (Friedman 1990). 
Other effects of benzimidazoles, specifically on A suum, have been 
reported, but are considered to be secondary mechanisms subsequent to 
microtubule disruption (Friedman 1990).  Mebendazole was shown to irreversibly 
inhibit glucose uptake resulting in a depletion of energy reserves (Friedman 
1990).  Mebendazole interferes with cytoplasmic microtubules in adult A suum 
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intestinal cells, resulting in disruption in the transport of secretory granules, cell 
lysis and death of the parasite (Friedman 1990). In the same study, a higher 
concentration of the drug was found in the intestinal cells than in other tissues of 
A suum.  In one study, A suum intestinal tissue showed a reduced uptake of 
sodium after treatment with benzimidazoles, but could have resulted from 
reduced glucose uptake (McKellar 1990). Several benzimidazoles also inhibited 
cytoplasmic and mitochondrial malate dehydrogenase and fumarate reductase in 
A suum (Friedman 1990, McKellar 1990). 
 
2.2.4 Spectrum and efficacy against Ascaris suum adults and larvae 
Fenbendazole is effective against a wide range of parasites and many 
larval stages, and is specifically labeled in swine for: Ascaris suum, Trichuris suis 
(swine whipworm), Hyostrongylus rubidus (small stomach worm), 
Oesophagostomum dentatum and O. quadrispinulatum (nodular worms), 
Metastrongylus apri and M pudendotectus (lungworms) and Stephanurus 
dentatus (kidney worm) (Kirsch 1975, Marti 1978, Stewart 1981, Becker 1981).   
For A suum, fenbendazole has been shown to be effective against the 
migrating L3 larvae within the liver and lungs, the pre-adult L4 larvae and the L5 
adults (Stewart 1981, Stewart 1984, Stewart 1986). This effectiveness is 
beneficial in that treatment of all larval stages present within a host or population 
at a single time, extends the period to re-shedding of infective eggs post 
treatment.  Anthelmintics that are only effective against adult stages, allow for 
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continued development of pre-adult larval stages and a shorter time to re-
shedding of eggs. 
In the early description of the molecule, Baeder noted that a single 5 
mg·kg-1 oral dose eliminated 100 percent of adult A suum from pigs, but did not 
provide details on the material and methods of the study, number treated or 
comparison to untreated animals (Baeder 1974). 
Fenbendazole was evaluated as an anthelmintic for swine in its initial 
commercial form of Panacur (Merck Animal Health, Summit, New Jersey), for 
effectiveness against Hyostrongylus rubidus and Oesophagostomum spp (Kirsch 
1975).  Kirsch and Düwel used single doses of 3.5 and 5 mg·kg-1 at 5, 16 and 42 
days post infection, and demonstrated a relatively lower efficacy in 5 day old 
worms (migrating larvae) than in 16 and 42 day old worms, with the exception of 
16 day Oesophagostomum spp. which had only 44 percent efficacy (Kirsch 
1975). 
Batte demonstrated efficacy of fenbendazole against A suum with single 
treatments of varying levels.  Single dose treatments of 3, 5, 7.5, 10, 15 and 25 
mg·kg-1 fenbendazole were 96.0, 76.9, 100, 96.8, 98.8 and 98.4 percent effective 
in expelling adult intestinal A suum (Batte 1978).  In addition, Batte showed 98.9 
and 100 percent efficacy of 3 or 5 mg·kg-1 daily doses for 3 days, respectively 
(Batte 1978). 
In another study where the efficacy of 3 and 5 mg·kg-1 fenbendazole daily 
for 3 days was studied against A suum, both treatments were 100 percent 
effective at removing adults (Stewart 1981).  Marti et al compared the efficacy of 
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different anthelmintics against A suum, with fenbendazole given at 3 mg·kg-1 for 
3 days (Marti 1978).  Feces was collected on day 0 and 5 and evaluated for 
worms and EPG, and all pigs were necropsied on day 7 and assessed for 
number of intestinal worms.  Fenbendazole was 92.4 percent effective at 
removing A suum from the intestine and reduced mean EPG by 76 percent at 
day 5 post-treatment (Marti 1978).  Düwel et al demonstrated that fenbendazole 
was 100 percent effective at removing adult A suum from experimentally 
challenged pigs when given at 0.33 mg·kg-1 daily for 15 days (Düwel 1980).   
Evaluation of fecal EPG in 35 naturally infected pigs treated with single 
doses of 5 (n=15) and 10 mg·kg-1 (n=15) fenbendazole or left as untreated 
controls (n=5), showed reduction in pre-treatment EPG levels (1,200-3,200) to 
zero by day 3, and remained negative at days 7, 14 and 21 post treatment, while 
controls had “no reduction” (Bali 1980). 
Becker and Bradley evaluated fenbendazole for the treatment of 
Stephanurus dentatus in naturally infected captured feral swine, but also reported 
on A suum fecal EPG and intestinal worms.  Pigs were treated with 3 mg·kg-1 for 
3 days and necropsied at 17 to 20 days post completion of treatment.  Fecal 
EPG was evaluated prior to treatment and again at necropsy, while number of 
intestinal worms were counted at necropsy.  In treated pigs, mean fecal EPG fell 
from 9,180 to zero and no intestinal worms were found at necropsy, while mean 
fecal EPG increased from 17,500 to 20,900 with 3.6 mean intestinal worms in 
control pigs (Becker 1981). 
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Kennedy et al evaluated the efficacy of fenbendazole against migrating A 
suum in pigs fed 3 mg·kg-1 daily for 3 days (days 1, 2 and 3 of challenge period) 
to pigs experimentally infected with 500 A suum eggs daily over a 14 day period. 
Fenbendazole did not prevent migration of all larvae through the liver and lungs, 
but did show a reduced number of intestinal worms at 28 days post inoculation 
as compared to controls (Kennedy 1987).  It should be noted that the 14 day 
exposure period would be longer than the anticipated treatment effect of 
fenbendazole given on days 1 through 3 of the experiment, and eggs ingested by 
pigs on days 5 through 14 would not be exposed to the effects of fenbendazole, 
based on the pharmacokinetics detailed above.   
Twelve pigs treated with 3 mg·kg-1 fenbendazole for 3 days, 50 days after 
inoculation with A suum eggs, had no intestinal worms 7 days after completion of 
treatment, as compared to a mean intestinal worm count of 64 in controls 
(Marchiondo 1987).  No fecal eggs were seen in treated pigs, while 5 of 9, 3 of 9 
and 7 of 9 control pigs were positive by fecal EPG at 21, 35 and 49 days 
(Marchiondo 1987). 
Kulkarni and Rao experimentally infected 3 pigs with 20,000 A suum eggs 
and treated (time post infection not reported) with 5 mg·kg-1 daily for 3 days and 
evaluated efficacy with pre- and post-treatment fecal EPG, expulsion of worms 
and number of worms at necropsy on day 4 post-treatment as compared to 3 
infected control pigs (Kulkarni 1990).  Fecal EPG were zero by day 3 post 
treatment in all treated pigs while fecal EPG of controls was 2,066 on the same 
sample day (Kulkarni 1990).  A mean of 6 worms were expelled during the 
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treatment period and no worms were found on necropsy in the treated pigs, while 
no worms were expelled and a mean of 9.3 intestinal worms were found at 
necropsy in control pigs (Kulkarni 1990). 
An evaluation of low dose fenbendazole against A suum was reported by 
Bjørn et al in which a dose of 0.35 mg·kg-1 was used to treat experimentally 
infected pigs, however there was no effect on excretion of A suum egg in the 
feces (Bjørn 1997).  It is unclear in this report as to the duration of treatment or 
the number of pigs evaluated. 
Maiti et al evaluated the response to fenbendazole by measuring fecal 
EPG in pigs treated with 7.5 mg·kg-1 for 2 days compared to untreated controls.  
A 68 percent reduction in mean EPG counts from 2,422 to 766 was seen 3 days 
after treatment and all animals were negative at days 7 and 14 post treatment, 
while control mean EPG remained above 2,000 (Maiti 2011). 
In recently reported work using a similar benzimidazole, flubendazole, 
Jourquin et al demonstrated the daily reduction in fecal EPG count and percent 
of subjects positive for A suum after treatment.  Sows were treated with either 1 
mg·kg-1 flubendazole for 5 consecutive days (n=11) or left as untreated controls 
(n=9) (Jourquin 2014).  Fecal EPG showed numeric, but not statistical 
differences starting 3 days after treatment and negative fecal EPG by 8 days in 
treated sows (Jourquin 2014). 
Fenbendazole has also been evaluated for its efficacy against the larval 
and migrating stages of A suum and found to be highly effective.  Stewart et al 
evaluated the efficacy of fenbendazole on migrating larvae while in the liver and 
53 
 
the lung by treating experimentally infected pigs with 3 mg·kg-1 for 3 days starting 
2 (liver) or 6 days (lung) after inoculation (Stewart 1984).  Pigs were euthanized 
24 days after inoculation and the mean number of A suum recovered in each 
treatment and control group were reported.  The mean number of worms 
recovered in the treatment groups was 0.62 and 0.25, for treatment start day 2 
and 6 respectively while mean number of worms was 133.57 for control pigs 
(Stewart 1984). 
Stewart et al inoculated pigs with embryonated A suum eggs on three 
occasions 11 days apart, each followed by a treatment of 3 days of 3 mg·kg-1 
fenbendazole, either on days 2 through 4 or 6 through 8 post-infection, in an 
attempt to elicit an immunological response.  Treated animals had a decreased 
number of pigs positive for A suum, a reduced mean number of worms per pig 
and the length and weight of the recovered worms was less than that of worms 
recovered from control animals (Stewart 1984/85). 
In a study targeting L4 larvae after liver and lung migration, Stewart et al 
treated pigs with 3 mg·kg-1 fenbendazole on days 8 through 10 post inoculation 
of L4 larvae and found no worms in any treated pigs 5 days post completion of 
treatment, while a mean number of 13.6 L4 and L5 worms were recovered from 
control pigs (Stewart 1986). 
It is recognized that extended treatment is more effective than single day 
treatment and may be necessary for complete treatment of some parasites (e.g. 
T suis) (McKellar 1990).  Corwin et al showed that there was no difference in 
feeding 9 mg·kg-1 total over periods of 3, 6 and 12 days on the removal of adult A 
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suum (Corwin 1984).  This was important, due to the fact that in many swine 
operations the application of a 3 day diet may be restrictive to feed milling and 
feed delivery efficiency and management at the farm level. 
A possible treatment regimen in swine breeding farms is to give only a 
single day of treatment of 3 mg·kg-1 to pregnant sows prior to farrowing (Jeremy 
Pittman, personal observation).  Batte showed a single treatment of 3 mg·kg-1 of 
fenbendazole was 96.0 percent effective in expelling adult A suum (Batte 1978).  
Praslička evaluated 0.05, 0.10, 0.25, 1.0 and 2.5 mg·kg-1 of fenbendazole 
against A suum in pigs.  Rates of 0.25, 1.0, and 2.5 mg·kg-1 had high efficacy 
against adult A suum, at 98.6, 99.9 and 100, respectively (Praslička 1997).  
Fenbendazole treatment rates of 1.0 and 2.5 mg·kg-1 had efficacy against 
immature worms, while other rates showed no efficacy (Praslička 1997).  While 
the single 3 mg·kg-1 and reduced treatment levels of fenbendazole appear to be 
effective, the limited amount of work may not be enough to support reduced 
doses in the field and should be studied further.  A summary of reported 
literature, found herein, on the effectiveness of fenbendazole on Ascaris suum 
can be found in Table 2.4. 
 
2.2.5 Ovicidal activity 
Members of the benzimidazole class of anthelmintics, namely 
thiabendazole, mebendazole and fenbendazole, have been shown to have 
ovicidal activity against helminths in humans (A lumbricoides), swine (A suum) 
and other species (Friedman 1980, Egerton 1969, Kirsch 1978, Carvalho 1992, 
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Boes 1998, Massara 2001).  Embryos exposed to benzimidazoles either in vivo 
or in vitro develop abnormally or fail to cleave during embryogenesis.  The 
ovicidal activity of benzimidazoles is related to its mode of action on tubulin.  
Work by Friedman and Platzer demonstrated an almost complete noncompetitive 
binding of fenbendazole and mebendazole to A suum embryonic tubulin with 
colchicine (Friedman 1980).  They proposed that the ovicidal activity was due to 
prevention of microtubule polymerization due to the benzimidazole molecule 
binding to the tubules.   
Egerton demonstrated complete inhibition of A suum embryo development 
with the parent benzimidazole, thiabendazole, at levels less than 1 ppm (Egerton 
1969).  Düwel reported ovicidal activity of fenbendazole against trichostrongylids 
at levels of 0.1 mg·kg-1 after 3 doses (Düwel 1977).  This effect was also seen in 
eggs in utero in adult female trichostrongylids.  Kirsch studied the ovicidal effects 
of fenbendazole in vivo and in vitro on three helminthes (Ostertagia ostertagi, 
Haemonchus contortus and Trichostrongylus colubriformis) of sheep.  With both 
in vivo and in vitro testing, Kirsch showed reduced embryonation of all three 
helminthes, and estimated that the 0.5 ppm in vitro concentration used was 
optimal for ovicidal activity (Kirsch 1978).  Additional work by Kirsch and Schleich 
demonstrated this ovicidal effect at an early stage in egg development, and even 
in utero, related to the formation of atypical blastomeres (Kirsch 1982). 
Wagner and Chavarria demonstrated rapid changes to Trichuris trichiura 
eggs from human patients as soon as 1 day after treatment with mebendazole.  
Changes included increases and decreases in size from normal, distorted 
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elongation and shapes, changes in the size and number of polar plugs and 
abnormal appearing yolk material.  In addition, many of these eggs (>92 percent) 
failed to develop to the larval stage (Wagner 1974b).  In another study by the 
same authors, they showed this same impact on T trichiura and also 
demonstrated complete ovicidal effect on human hookworm eggs after 1 day of 
treatment with mebendazole (Wagner 1974a).  Carvalho et al demonstrated 
reduced embryonation of A lumbricoides eggs extracted from the uteri of 
expelled adult females in patients treated with thiabendazole (Carvalho 1992).  
Ovicidal effects have also been shown with albendazole against A lumbricoides 
(Maisonneuve 1985).  Massara et al demonstrated a complete ovicidal effect of 
thiabendazole in A lumbricoides eggs eliminated in patients by 48 hours after 
treatment.  In addition, eliminated eggs had a reduced infectivity as measured by 
retrieval of larvae from lungs and hearts of challenged mice 48 and 72 hours 
after infection (Massara 1991).  When thiabendazole was used in vitro on eggs 
from expelled A lumbricoides of human patients at different concentrations and 
for different times, a dose and time dependent effect was observed on 
embryonation.  Dilutions of thiabendazole at 1 and 2.5 ppm did not have an effect 
on embryonation.  Concentration of 5 ppm had a 0 to 31 percent reduction in 
embryonation at 72 hours post-treatment, while 10 ppm resulted in 0 to 72 
percent reduction at 24 hours and 100 percent at 48 and 72 hours post-treatment 
(Massara 2001). 
Lacey et al studied the effects of different benzimidazoles and their 
metabolites on egg hatch in vivo of Haemonchus contortus from sheep.  The egg 
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hatch rate was reduced when the metabolites of fenbendazole were used, 
compared to fenbendazole.  Sulfur-oxidation to fenbendazole sulphoxide reduced 
ovicidal activity 40-fold and was not active with fenbendazole sulphone (Lacey 
1987).  In addition, the hydroxylation, oxidation and decarbamoylation of 
fenbendazole also reduced or eliminated the ovicidal effects of fenbendazole.  
The authors hypothesized this reduced efficacy could have been due to an 
inability of the polar metabolites to penetrate the egg’s shell, rather than inability 
to inhibit the tubule structures (Lacey 1987).  Therefore it is likely for A suum that 
the ovicidal activity observed with fenbendazole is due in large part to the parent 
molecule fenbendazole, and not to its metabolites. 
Ascaris suum egg embryonation and infectivity was evaluated in eggs 
from expelled worms from pigs treated with albendazole, pyrantel, ivermectin and 
piperazine.  In the albendazole group, only 7 percent of the eggs developed into 
larval stages, while most were arrested at the one-cell stage (Boes 1998).  The 
other anthelmintics had no significant impact on embryonation rates. When 
remaining embryonated eggs were inoculated into mice, there was no significant 
difference in larvae recovered from albendazole treated eggs compared to 
control eggs, suggesting fenbendazole did not affect hatchability or infectivity of 
those eggs that fully developed to L3 larvae (Boes 1998). 
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2.2.6 Tables 
 
Table 2.2 Chemical structure of fenbendazole and its sulphoxide (oxfendazole) 
and suphone metabolites. 
Benzimidazole Chemical Structure* 
Fenbendazole 
 
Oxfendazole (FBZ sulphoxide) 
 
Fenbendazole Sulphone 
 
* Chemical structure images from http://wwwchemicalbook.com; visited Dec 16, 
2011. 
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Table 2.3 Pharmacokinetic parameters (means ± SD) of fenbendazole and 
metabolites in pigs given one 5 mg·kg-1 dose orally. 
 
Parameter 
 
Petersen and Friis, 2000 (n=4) 
Szprengier-
Juszkiewicz  
et al, 2002 (n = 8) 
Fenbendazole Oxfendazole 
Fenbendazole 
sulfone 
Oxfendazole + 
Fenbendazole 
sulfone 
Tmax (h) 3.75 ± 1.50 12.50 ± 8.06 28.50 ± 3.00 17.0 ± 7.6 
Cmax 
(ug/mL) 
0.07 ± 0.04 0.66 ± 0.22 0.24 ± 0.09 0.133 ± 0.032 
Thalf (h) 8.38 ± 4.28 NR NR NR 
PCT Total 
AUC 
4.5 ± 1.6 65.9 ± 10.0 29.7 ± 10.6 NR 
AUC 
(ug*h/mL) 
1.00 ± 0.34 15.61 ± 5.24 7.04 ± 3.08 3.5 ± 0.60 
 
From Petersen and Friis, 2000 and Szprengier-Juszkiewicz et al, 2002 
AUC = area under the curve. PCT Total = percent of total AUC. Thalf = Half life. 
Cmax = Maximum plasma concentration. Tmax = Time to Cmax. NR = Not reported. 
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Table 2.4 Review of published literature for fenbendazole efficacy against Ascaris suum. 
Reference Dose 
Treatment 
Duration 
n 
Determinant 
of efficacy 
Result Comments 
Baeder et al, 
1974 
5 mg·kg-1 1 day NR 
Percent elimination 
of intestinal adults 
100   
Batte, 1978 
3 mg·kg-1 
1 day 
12 
Percent worms 
expelled at 5 dpt 
96.0 
 
5 mg·kg-1 12 76.9 
7.5 mg·kg-1 10 100 
10 mg·kg-1 20 96.8 
15 mg·kg-1 20 98.8 
25 mg·kg-1 10 98.4 
3 mg·kg-1 
3 days 
12 Percent worms 
expelled at 7 dpt 
98.9 
5 mg·kg-1 12 100 
Marti et al, 
1978 
3 mg·kg-1 3 days 11 
Fecal EPG reduction 
at 5 dpt 
92.4 
Avg EPG reduced 
from 1,158 to 276 
Bali and 
Singh, 1980 
5 mg·kg-1 1 day 15 
Mean fecal EPG at 
3, 7, 14 and 21 dpt 
0 
Pre-treatment EPG 
range was 1,200-
3,200 
10 mg·kg-1 1 day 15 0 
Control --- 5 
No 
reduction 
Becker and 
Bradley, 
1981 
3 mg·kg-1 3 days 10 
a) Mean fecal EPG 
pre and 17-20 dpt 
b) Mean worms at 
necropsy at 17-20 
dpt 
a) 9,180 to 
0 
b) 0 Naturally infected 
feral swine 
Control --- 10 
a) 17,500 to 
20,900 
b) 3.6 
Stewart et al, 
1981 
3 mg·kg-1 3 days 11 
Mean worms in 
intestine at 4-5 dpt 
0 
 5 mg·kg-1 3 days 11 0 
Control --- 11 1.7 
Corwin et al, 
1984 
3 mg·kg-1 3 days 10 
Worms in intestine a 
4-8 dpt 
0 
 
1.5 mg·kg-1 6 days 10 0 
0.75 mg·kg-1 12 days 10 0 
Control --- 10 18 
Stewart et al, 
1984 
3 mg·kg-1 
3 days  
(2-4 dpi) 
8 
Mean intestinal 
worm recovery at 24 
dpi 
0.62 
Targeted migrating 
larvae 3 mg·kg-1 
3 days  
(6-8 dpi) 
8 0.25 
Controls --- 8 133.6 
Stewart and 
Rowell, 1986 
3 mg·kg-1 
3 days 
(8-10 dpi) 
8 
Mean intestinal 
worm recovery 15 
dpi 
0 Targeted 4th stage 
larvae 
Controls --- 8 13.6 
Kennedy et 
al, 1987 
3 mg·kg-1 
3 days 
(1-3 dpt) 
10 
Number of larvae in 
intestine 14 and 24 
dpi 
80 
Pigs exposed to 500 
eggs daily for 14 
days Controls --- 10 250 
Marchiondo 
and Szanto, 
1987 
3 mg·kg-1 3 days 10 
a) Positive EPG 25, 
35 and 49 dpt 
b) Mean worms 7 
and 81 dpt 
a) 0, 0, 0 
b) 0, 0.8 
 
Controls --- 10 
a) 5, 3, 7 
b) 64, 2.78 
Kulkarni and 
Rao, 1990 
5 mg·kg-1 3 days 3 
a) EPG reduction 
pre and 3 dpt 
b) Mean worms 
voided 24-72 hpt 
c) Mean intestinal 
worms at 4 dpt 
a) 3,822 to 
356 
b) 6 
c) 0 Pigs infected with 
20,000 eggs 
Control --- 3 
a) 2,300 to 
2,188 
b) 0 
c) 9.3 
Maiti et al, 
2008 
7.5 mg·kg-1 2 days 10 
Fecal EPG 0, 3, 7 
and 14 dpt 
d0: 2,422 
d3: 766 
d7: 0 
d14: 0 
 
Control --- 10 
d0: 2,207 
d3: 2,285 
d7: 2,309 
d14: 2,355 
NR=not reported, dpi=days post inoculation, dpt=days post treatment, EPG=eggs per gram 
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3.1 Summary 
Objective: To determine the time to cessation of Ascaris suum egg shedding, 
the percent of animals that stop shedding, and to estimate the reduction in 
environmental burden from eggs shed in naturally infected female breeding 
swine after different treatment levels of fenbendazole to better determine timing 
of anthelmintic use prior to movement into a farrowing environment. 
 
Materials and methods: Five experiments across three commercial sow farms, 
known to be infected with A suum were conducted. Breeding gilts and sows were 
identified with natural A suum infections and allocated to one of 4 treatments; 
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CNT = untreated controls, TX1 = 545.5 mg fenbendazole for one day, TX2 = 
545.5 mg fenbendazole daily, for 3 consecutive days (1636.5 mg total), TX3 = 
1636.5 mg fenbendazole for one day. Fecal samples were collected on various 
days and evaluated using the modified Wisconsin sugar flotation technique.  
Time-to-negative was evaluated using Kaplan-Meier survival analysis, percent 
negative was evaluated by Chi-square analysis and environmental burden 
(BURD) (eggs observed versus eggs expected) was evaluated by analysis of 
variance. 
 
Results:  Mean time-to-negative ranged from 9.3 to 13.1 for TX1, 8.9 to 13.1 
days for TX2 and 9.8 for TX3, while CNT ranged from 13.4 to 28.2 with 70 to 100 
percent censored.  For all TX, 90 to 100 percent of sows were negative by the 
end of the study, compared to 0 to 28.6 percent for CNT.  Mean BURD range 
was 7.0 to 60.9 for TX1, 13.9 to 60.8 for TX2, 29.3 for TX3 and 60.4 to 219.0 for 
CNT.  All TX were different from CNT (P<0.05) but not from each other. 
 
Implications:  Fenbendazole was effective at all treatment levels in decreasing 
the number of A suum eggs shed into the environment.  When using 
fenbendazole for the control of A suum transmission from dams to offspring, 
treatment should begin approximately 14 days prior to movement into clean 
farrowing facilities. 
 
Key words: swine, Ascaris suum, fenbendazole, eggs, shedding  
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3.2 Introduction 
The Large Roundworm of swine, Ascaris suum (A suum), has worldwide 
distribution and can be found in all types of swine operations. (Roepstorff 1994, 
De Bie 2003, Greve 2012, Pelger 2012a-d)  Changes in modern swine 
production systems that decrease contacts with intermediate hosts and 
environments, increased sanitation, separation of production stages, and use of 
effective anthelmintics, have created the perception that the incidence and 
severity of swine parasites in general has declined.  Some producers and 
veterinarians have developed a false assumption that raising pigs indoors 
completely prevents parasitism, and hence parasites are often not considered to 
be of major importance in modern swine production.  However, due to several 
key characteristics of A suum, the parasite persists in modern production 
systems (Roepstorff 1994, Johnson 2003, Melancon 2005, Pittman 2010a,b).  
Those characteristics are a highly fecund adult female roundworm (estimated to 
produce 1 to 2 million eggs per day) (Kelley 1956, Olsen 1958), eggs that are 
highly resistant to environmental influences and disinfectants (Wharton 1979, 
Gaasenbeek 1998, Roepstorff 1998), a direct life cycle involving extra-intestinal 
migration (Roepstorff 2003), and a relatively short patency period (6-8 weeks) 
(Roepstorff 2003).  These characteristics combined with common oversight, 
allow infected carriers to enter into negative sites or continue contaminating 
already positive sites (Connor 2012).  The capacity for rapid environmental 
contamination and inherent resistance of the eggs makes it nearly impossible to 
80 
 
eradicate the parasite from contaminated facilities, thus continued monitoring, 
treatment and control measures are required (Myers 1988, Roepstorff 1998). 
Current trends in the swine industry will permit an increase in swine 
parasite prevalence as a consequence of exposure to epidemiological risk 
factors (Dangolla 1996b, Sundrum 2010, Roepstorff 2011).  Such changes 
including housing pregnant sows in groups, requiring provision of nesting or 
bedding materials and restrictions of drug use will inevitably result in systems 
that permit A suum transmission and increased prevalence within farms 
(Haugegaerd 2010, Roespstorff 2011).  The increase in niche production 
systems (eg. organic, differentiated markets, welfare-friendly, pasture raised) and 
swine associated with regional and national exhibition show circuits provide 
environments that maintain parasites, especially A suum (Eriksen 1996, 
Cartensen 2002, Eijck 2005, Yaeger 2009, Woods 2012). 
The main economic impacts of A suum in swine are reduced feed 
efficiency (Hale 1985, Stewart 1988), decreased average daily gain (Nilsson 
1980, Bernardo 1990a, Kipper 2011), increased liver condemnations at slaughter 
due to larval migration and organ pathology ("milk spots" on livers) (Bernardo 
1990b, Hurnik 1995, Harr 2001, Kanora 2004, Meisinger 2004, Melancon 2005, 
McOrist 2008) and increased medication costs related to treatment (Boes 2010, 
USDA 2007).  Additional A suum impacts include reduced vaccine efficacy from 
migrating larvae (Urban 2007, Steenhard 2009), organ damage from larval 
migrans (i.e, lung, liver, small intestine, stomach) predisposing the host to 
secondary diseases (Shope 1958, Underdahl 1957, Nayak 1965, Qureshi 1978, 
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Matusyavichus 1985, Curtis 1987, Adedeji 1989, Tjørnehøj 1992, Vyt 2004, 
Engle 2006, Jourquin 2008), morbidity and mortality associated with acute 
infection (Perry 1993, Gjestvang 2004, Trujano 2014), impaction (i.e., intestinal, 
bile duct) (Greve 2012), a potential for reduced reproductive performance in 
sows (Pattison 1979, Hagsten 1984) and impacts on carcass and meat quality 
(Knecht 2011, Knecht 2012). A suum periodically affects other livestock species, 
primarily as pneumonia in young animals (McCraw 1971, McLennan 1974, Gunn 
1980). A suum can be a zoonotic infection in areas where humans and swine 
cohabitate (Lord 1982, Shoemaker-Nawas 1982, Anderson 1995, Nejsum 2005, 
Arizono 2010, Bendall 2011, Dold 2011, Nejsum 2012, Zhou 2012, Colby 2013). 
The goal for most parasite control programs is to minimize the production 
impact through preventing transmission and reducing environmental 
contamination (Raffensperger 1927, Behlow 1978, Biehl 1987, Myers 1988, 
Stewart 1993). This is accomplished by increased sanitation, management of pig 
flow and use of anthelmintics at key times in the parasite’s life cycle and the 
host’s production cycle.  Common practice in the swine industry is to provide an 
anthelmintic to sows prior to farrowing before they enter clean farrowing facilities 
(Myers 1988, Roepstorff 1998a).  This reduces transmission to the farrowing 
environment (eg. stall, pasture, etc) and from the sow to piglets.  Treatment 
timing prior to farrowing can vary considerably and if insufficient time elapses 
before farrowing to allow cessation of fecal shedding into the farrowing 
environment, offspring exposure is not prevented. 
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Fenbendazole is a broad spectrum benzimidazole (Class I anthelmintic) 
approved for use in swine by the FDA.  Fenbendazole has a wide safety margin, 
is highly effective against both the adult and larval stages of A suum, and has 
ovicidal activity against the eggs of many helminths (Batte 1978, Friedman 1980, 
Corwin 1984, Stewart 1984, Stewart 1986).  It is currently available in North 
America as a feed additive (Safe-Guard Medicated Dewormer for Swine, Merck 
Animal Health, Summit, New Jersey) or as an individual feed top-dress (Safe-
Guard EZ Scoop, Merck Animal Health, Summit, New Jersey).  The drug is also 
available for other species in North America and for swine in the other countries 
under the trade name Panacur (MSD Animal Health, Summit, New Jersey).  The 
individual top-dress can be considered as therapeutic and enables judicious 
treatment of individual animals or subpopulations without requiring 
simultaneously medicating the entire population served by the feed system.  It 
also eliminates the need for on-farm feed mixing, which may not be available. 
The US label for Safe-Guard EZ Scoop states; “For Individual 400 lb Sow 
Feeding: Mix 1 level scoop (1.07 ounces) of Safe-Guard® EZ Scoop® premix into 
4 to 6 lbs of an individual 400 lb sow’s daily ration and feed once daily for 
3 consecutive days”.  However, off-label treatment of sows with a single day, 
single scoop dose of Safe-Guard EZ Scoop, equating to a 3 mg·kg-1 dose for a 
181.8 kg animal is commonly used (Jeremy Pittman, personal observations).  In 
addition, farms usually do not weigh individual animals prior to applying 
fenbendazole using the Safe-Guard EZ Scoop (Dangolla 1996a, Jeremy Pittman, 
personal observations).  Therefore, treatment may be less than indicated by both 
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dose and duration.  The consequence of imprecise dosing and abbreviated 
treatment regimen on A suum egg shedding has not been thoroughly evaluated.  
In early studies of fenbendazole in swine, Baeder et al used a single oral dose of 
5 mg·kg-1 and eliminated 100 percent of adult A suum from the intestine and 
Batte demonstrated the efficacy (96.0 percent adult A suum removed) of 3 
mg·kg-1 as a single dose (Baeder 1974, Batte 1978).  Extended treatment (3 
days or longer) with fenbendazole, even with a lower daily dose, is usually 
considered more effective than single doses, namely for treatment of Trichuris 
suis (Batte 1978, McKellar 1990).   
While fenbendazole use in swine has been demonstrated in small group 
infections, useful information about the drug’s impact on population dynamics of 
A suum in dynamic, commercial pig populations is not available.  Judicious drug 
use would be supported by evidence of the magnitude of impact on shedding, 
shedding duration and time to negative shedding post-treatment under 
commercial conditions.  The experiments presented herein were conducted to 
characterize the impact of fenbendazole on A suum egg shedding in naturally 
infected gestating sows under commercial conditions with commonly used 
protocols. 
 
3.3 Materials and Methods 
3.3.1 Farms 
The herds in which the experiments were conducted were sow farms in a 
commercial swine production company, using Large White-Landrace cross 
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maternal genetics, between 2010 and 2013.  All animals were cared for in 
accordance with the Guide for the Care and Use of Agricultural Animals in 
Research and Teaching 
(http://www.fass.org/docs/agguide3rd/Ag_Guide_3rd_ed.pdf) and Pork Quality 
Assurance Plus (PQA Plus) guidelines 
(http://www.pork.org/Certification/2341/pqaPlusMaterials.aspx).  Farms A, B and 
C were selected because they had each been previously diagnosed with A suum 
infection in breeding sows as part of a system surveillance study (Pittman 
2010a).  Farm A was a 1,000-sow one-site farrow-to-finish operation located in 
Southeastern Virginia.  Farm B and C were each 2,000 farrow-to-feeder pig (10 
wks of age) operations, both located in Northeastern North Carolina.  All farms 
were managed with weekly batches of gestating, multiparous sows which were 
housed in individual gestation and farrowing stalls, weaning pigs at 
approximately 3 weeks of age.  Replacement gilts were housed in pens in groups 
of 4 to 5 until bred, at which time they were moved into individual gestation stalls.  
All farms utilized fenbendazole as a feed top-dress (Safe-Guard EZ scoop), 
weekly to gestating groups of sows 2 weeks prior to farrowing, but all routine 
fenbendazole use was suspended prior to the start of the experiment and for the 
duration.  Animals were fed individually through automated drop boxes one time 
per day and individual water nipples were available for each animal at all times. 
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3.3.2 Experiments 
Five separate experiments were conducted; one at Farm A and B each 
and three at Farm C.  Each experimental design differed slightly with regard to 
collection dates, treatments and duration.  All subject enrollment, sample 
collection, sample processing and application of treatments was consistent 
between experiments.  No animals were used in more than one experiment at 
Farm C. 
 
3.3.3 Sow inclusion and exclusion criteria 
Based on reported literature and previous observations in the herd, 
younger parity animals (gilts through second parity sows) were initially screened 
for A suum infection status, due to a higher expected prevalence of infection 
(Marti 1986, Roepstorff 1998b, Nosal 2008).  The goal was to identify gestating 
adult females shedding A suum eggs in their feces.  In order to screen a large 
number of animals in an efficient and rapid manner, a modified fecal flotation 
method was utilized.  Approximately 1 gram of feces was collected directly from 
the rectum of selected gilts and sows.  A new clean nitrile glove was used for 
each animal to prevent sample cross-contamination.  Fecal samples were placed 
in a 15 mL centrifuge tube (VWR, Radnor, Pennsylvania) with a screw top lid, 
pre-filled with 5 mL of a concentrated sugar solution (Sheather's solution; 454 g 
sugar in 355 mL water with specific gravity of 1.27) (David 1982).  Samples were 
processed immediately on site.  Fecal samples and sugar solution were 
homogenized within the 15 mL tube manually by vigorously shaking the tube.  
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Supplemental homogenization, if required, was accomplished using a disposable 
wooden stirrer that was discarded after a single use.  Tubes were placed in test 
tube racks and a volume of sugar solution added sufficient to create a meniscus 
at the top of the tube.  A 2 cm by 2 cm glass coverslip was placed on top of each 
tube and allowed to sit for a minimum of 10 minutes.  Coverslips were removed, 
placed on a glass microscope slide and examined under 40X magnification (4X 
objective and 10X eyepiece) for presence of A suum eggs.  Each coverslip was 
examined until confirmation of at least 1 egg was observed or the entire coverslip 
determined to be negative.  Animals with at least 1 A suum egg were considered 
positive and enrolled into the study.  Animals where no eggs were observed from 
their fecal sample were considered negative and excluded from the experiments. 
 
3.3.4 Treatments 
Treatments were applied in a manner consistent with existing on-farm 
processes.  Gilts and sows were not weighed at any point in the experiments.  
Safe-Guard EZ Scoop was used for all fenbendazole treatments, and subject 
dose allotments were established using the manufacturer’s scoop provided in the 
package.  The scoop, when level full, provides approximately 545.5 mg of 
fenbendazole, sufficient to provide 3 mg·kg-1 bodyweight to a 181.8 kg animal.  In 
practice, a single full scoop is provided to each sow, regardless of bodyweight, 
and treatments were based on this methodology. 
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Five experiments were conducted to compare egg shedding patterns over 
time between four treatments.  Treatments were: control with no treatment 
(CNT), a single 545.5 mg scoop of FBZ for one day (TX1), a single 545.5 mg 
scoop of FBZ daily for three consecutive days (total 1636.5 mg) (TX2), or three 
545.5 mg scoops of FBZ on a single day (total 1636.5 mg) (TX3).  In experiments 
1 through 4, subjects were randomly assigned into CNT, TX1 or TX2.  In 
experiment 5, sows were randomly assigned to CNT, TX1, TX2 or TX3 groups.  
Anthelmintic intake was monitored by ensuring each sow consumed their entire 
feed allotment prior to the next feeding.  Sows that did not completely consume 
medicated feed were dropped from the study and not included in the analysis.  A 
summary of the experimental design, treatments and number of sows in each 
treatment can be found in Table 1.  
 
3.3.5 Sample collection and processing 
At each sample day, individual fecal samples were collected directly per 
rectum from each enrolled sow.  Fecal collection days varied by experiment and 
a summary of sampling days by experiment can be found in Table 1.  A new 
clean nitrile glove was used for each fecal collection.  Approximately 5 grams of 
feces was extracted from the rectum of each sow.  If feces were not readily 
available, collection was attempted later the same day.  If a fecal collection from 
a sow failed in two attempts they were excluded from the day's collection.  After 
collection, fecal samples were placed into 50 mL screw-top centrifuge tubes 
(VWR, Radnor, Pennsylvania) and labeled appropriately.  Samples were kept 
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refrigerated until processing which occurred within 24 to 72 hours after collection.  
Samples were either processed in-house by the primary author or submitted to 
the secondary author’s laboratory (Myers Parasitology Services, Magnolia, 
Kentucky) using the same methodology with consistent qualitative results 
between laboratories as determined by a priori comparisons (kappa = 0.96). 
Samples were processed using the modified Wisconsin sugar flotation 
technique (Bliss 1997).  Sheather’s solution was evaluated for a specific gravity 
of 1.27 with a hygrometer (David 1982).  Sample homogenization occurred within 
the 50 mL collection tube prior to collecting a 2 gram sub-sample.  The 2 gram 
sub-sample was homogenized with 15 mL of Sheathers' solution in a 147.8 mL 
wax paper cup using a disposable wooden stick.  The fecal-sugar solution 
homogenate was strained into a second wax paper cup through a tea strainer to 
remove large organic particles.  The strained homogenate was then transferred 
to 15 mL centrifuge tube and a volume of Sheather's solution added to restore a 
total volume to 15 mL.  Tubes were centrifuged at 145.5 x g for 10 minutes.  
Centrifuged tubes were placed in a test tube rack and a sufficient volume of 
Sheather's solution was added to each tube until a meniscus was formed.  A 2 
cm by 2 cm coverslip was placed on the meniscus and remained for a minimum 
of 10 minutes.  The coverslip was removed and placed on a microscope slide for 
evaluation.  Slides were evaluated using 40X magnification and the A suum eggs 
number on the entire slide was counted.  To calculate the egg per gram (EPG) of 
feces, the total number of eggs was divided by 2 (initial grams of feces used).  
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Samples with greater than 500 EPG were recorded as 500 eggs.  Samples were 
considered positive if at least 1 egg per coverslip was identified. 
 
3.3.6 Statistical analysis 
All statistical analyses were completed using Enterprise Guide 5.1 
software (SAS Institute, INC, Cary, North Carolina).  In each case sow was 
considered the experimental unit.  The dependent variable in each study was the 
duration of fecal A suum egg shedding measured as the time to first negative 
fecal exam from experimental sows. Survival analysis (PROC LIFETEST) was 
used and the model included treatment group, farm (in the case of experiments), 
parity and treatment-farm interaction fixed effects and the random effect of sow 
within farm by treatment group.  Effects determined non-significant based on 
analysis were dropped from further analysis.  Comparisons between treatment 
groups were made using Kaplan-Meier methods as an estimation for survival 
function from life time data.  Mean survival times (±SE) were estimated for each 
treatment.  Additionally, the percentage of animals that produced a negative fecal 
exam by the end of the study was evaluated using Chi-Square and Fisher’s exact 
test methods.  A calculated mean environmental burden (BURD) value for each 
treatment group were evaluated using analysis of variance methods to evaluate 
treatment effects and treatment means were separated using Tukey’s 
studentized range test. The model implemented included treatment group, farm, 
parity and treatment-farm interaction fixed effects.  The BURD calculation was an 
attempt to compare observed eggs excreted [EPGobs] for the duration of the 
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study period compared to an expected eggs excreted [EPGexp] for each sow and 
between treatments as a measure of the potential environmental contamination 
provided by each group.  An individual’s EPGexp value was that individual’s initial 
(day 0) EPG multiplied by the total duration days of the study.  The EPGobs value 
was calculated as the cumulative sum of EPG at one sampling day (Di) times the 
number of days until the next sampling day (Di+x) through the duration of the 
study [∑(EPGDi x (Di+X – Di))].  For example, an animal has sample day EPG 
values of 100, 80 and 20 on days 0, 4 and 8 respectively.  The EPGexp for this 
particular animals is 900 [100 EPGDay0 x 9 total days], the EPGobs is 740 [(100 
EPGDay0 x 4 days)+(80 EPGDay4 x 4 days) + (20 EPGDay8 * 1 day)], and the BURD 
is 0.822 [740 EPGobs /900 EPGexp].  This BURD estimate represents that the 
individual shed 82.2 percent of the eggs over the study duration as was 
anticipated for that individual.  
 
3.4 Results 
In the survival analyses there were significant farm (experiment) effects 
(P<0.0001), and evidence of a trend in farm-treatment interaction (P=0.0540) in 
the full model, therefore data was analyzed and reported independently by 
experiment in a reduced model.  There was no parity effect and was therefore 
excluded from the reduced models.  In each experiment there was a high 
censoring rate in the CNT groups (range 70.0 to 100.0 percent), as many 
subjects remained positive throughout the period of testing.  In each experiment, 
Kaplan-Meier survival analysis demonstrated a significant difference in time-to-
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negative egg shedding between CNT and each treatment group.  In all 
experiments, TX1, TX2 and TX3 were not different between one another.  Mean 
time to negative egg shedding for CNT groups were 18.0 (SE 0.0), 14.0 (0.0), 
22.3 (1.6), 28.2 (1.5) and 13.4 (0.8) for experiments 1 through 5 respectively.  
Mean time to negative for TX1 groups were 13.1 (0.9), 9.3 (1.0), 11.7 (0.4), 11.5 
(0.7) and 9.5 (0.6) in experiments 1 through 5 respectively.  Mean time to 
negative for TX2 groups were 11.0 (1.2), 10.6 (0.8), 11.3 (0.5), 13.1 (1.0) and 8.9 
(0.8) in experiments 1 through 5 respectively.  In experiment 5, TX3 survival time 
was 9.8 (0.7).  Complete mean time-to-negative, standard error, range and 
percent censored for each experiment can be found in TABLE 2.  A graph of the 
survival analysis has been included (Figure 1) for all of the data from 
experiments 1 through 5 combined.  Note that due to the different durations of 
the 5 experiments, the CNT group contains a large percentage of censored data 
points, while the most number of sows censored in any fenbendazole treated 
group or experiment was one.  Therefore this graph significantly underestimates 
the impact of fenbendazole treatments and is a conservative assessment. 
When combining all experiments, only 9 of 40 (22.5%) CNT animals were 
negative for A suum eggs throughout the respective study periods.  Of the 
treatment groups, 66 of 67 (98.5%) for TX1, 65 of 67 (97.0%) for TX2 and all of 
11 (100.0%) TX3 were negative for A suum eggs at respective experiment 
completion.  The percent negative at end of study differences between CNT and 
each treatment was significant by Fisher’s exact test (P<0.0001).  There was no 
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difference in percent negative at end of study between TX1, TX2 or TX3 in any of 
the five experiments.  The results for each experiment can be found in TABLE 3. 
For BURD analysis, a significant effect of treatment (P<0.0001) and farm 
(P=0.0003) and a trend towards significance in the treatment-farm (P=0.0540) 
interaction was observed, therefore data was analyzed and reported by 
experiment.  The BURD analysis demonstrated a significant difference (P<0.05) 
between CNT and all fenbendazole treatments in each experiment by Tukey’s 
studentized range test.  There was no difference between TX1, TX2 or TX3 in 
any of the five experiments.  The BURD estimate for individuals in some 
experiments were greater than 1.00 as a result of increased EPG counts on 
subsequent samplings from their day 0 EPG value.  It should be noted that while 
significant, the BURD values in experiment 2 between CNT (79.9) and TX1 
(60.9) and TX2 (60.8) are numerically not very different as compared to the other 
experiments.  This is likely due to several factors, including the shorter duration 
of study (14 days), the number of sampling days (4) and the bias of “capping” 
initial fecal EPG values described below.  Average BURD and 95 percent 
confidence intervals are listed for each experiment in TABLE 4. 
It is important to note that in some fecal samples, EPG was in excess of 
the 500 EPG cut-off used, and thus could introduce bias into the BURD 
calculation.  Overall, the use of an EPG “cap” in these experiments resulted in an 
underestimation of the impact of reduced fecal shedding.  In Experiment 1 there 
were no recorded samples above 500 EPG.  In Experiment 2, two TX1 and three 
TX2 at day 0 were above 500.  In Experiment 3, a CNT sample at day 8 and 10 
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and one TX2 day 0 sample were above 500.  In Experiment 4, eleven CNT 
samples were greater than 500, with 10 of the eleven coming between days 8 
and 22 of sampling, while ten TX1 and six TX2 day 0 samples were above 500 
EPG.  There was one TX1 day 8 sample greater than 500 in experiment 4.  In 
Experiment 5, one TX2 and TX3 day 0 sample each had above 500 EPG, while 
one CNT sample on days 8, 10 and 21 had a fecal EPG above 500.  All but one 
of the above observations (Experiment 4 TX1 day 8 sample) would have resulted 
in underestimation of the actual BURD calculation, since sample “capped” at day 
0 would have resulted in a lower expected BURD value and CNT samples 
“capped” post-treatment would have underestimated the reduced BURD 
compared to treatment groups.  This could explain the more minimal numerical 
differences and reduction in CNT BURD values observed in Experiments 2 and 
4, as compares to Experiments 1, 3 and 5.  It is not well understood how this 
influences transmission or clinical disease as fecal EPG values are not well 
correlated with disease burden and are inherently highly variable in swine and 
are not well understood (Roepstorff 1998a). 
 
3.5 Discussion 
The results from the experiments presented here, suggest using 
fenbendazole in breeding females prior to farrowing, and treatment should begin 
14 days prior to moving sows into clean farrowing facilities in order to minimize A 
suum eggs shedding into that environment.  Treatment of breeding herd animals 
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after this time or upon entry into the farrowing facility will likely result in some 
facility contamination and increase transmission risk to suckling piglets. 
The number of sows in each experiment and between treatment groups 
varies considerably, as compared to other reported literature.  Since the 
experiments were completed on naturally infected sows on commercial farms, 
and due to the method of enrollment described above, in which a rapid survey of 
a large number of animals was conducted, there was significant exclusion of 
subjects after enrollment.  The initial screening of sows was conducted on a large 
number of animals (e.g. 100 to 250), on-farm and initially positive animals were 
randomly allotted to treatment groups.  Initial allocations attempted to place an 
equal number of sows per treatment group in experiments 1, 2, 3 and 5, while in 
experiment 4 twice as many sows were enrolled in TX1 and TX2 as in the CNT 
group.  After allotment, the day 0 fecal sample was collected and treatment was 
initiated.  Initial screening, enrollment, day 0 fecal collection and treatment were 
all conducted on-farm on the same day within experiments in order to be more 
efficient.  Once the day 0 fecal sample was processed and “false positives” from 
the initial screening were determined, those sows were excluded from the study, 
resulting in uneven treatment groups for data collection and analysis.  
While egg per gram was recorded, comparison of EPG between 
treatments was not considered due to the inherent high variability of egg counts 
when assessing A suum infection.  Egg counts are highly variable over time 
within the same subject as well as within the same fecal passing (Roepstorff 
1998a, personal observations), therefore use of absolute counts or snapshots 
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can be very misleading.  Interpretation of fecal EPG counts in swine are difficult 
because egg counts are not well correlated with worm burden or clinical impact 
(Roepstorff 1998a).  In addition, the main goal of these experiments where to 
assess the time to cessation of shedding, and not necessarily a reduction in 
average EPG.  Therefore use of a calculated burden (BURD) was utilized, which 
may provide a better description of egg shedding as it represents an average of 
fecal egg counts over several time periods, rather than use of a single time point.  
The estimation of BURD in this paper is an attempt to describe the level of 
environmental contamination by the different treatment groups, which is an 
important epidemiological aspect of A suum control.  Others have utilized similar 
calculated estimates of egg contamination.  Bernardo et al used the average egg 
per gram count between consecutive visits multiplied by the time elapsed 
between those visits to calculate a raw “lifetime burden” in market pigs (Bernardo 
1990a).  Those values were then standardized to an average lifetime burden to 
generate a value relative to 1 (average lifetime burden) and used in models to 
determine growth impacts of ascariasis.  Mejer et al calculated a “relative 
contamination index” from fecal egg counts of Trichuris suis and 
Oesophagostomum dentatum in pastured pigs as an attempt to compare 
contamination rates between experimental paddocks (Mejer 2006).  The 
calculation utilized in this paper was an attempt to demonstrate the impact of 
fenbendazole treatment on reduction of total eggs excreted into the environment, 
while accounting for the theoretical contamination if those animals were not 
treated.  As can be noted by the increased BURD values in CNT in experiments 
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1, 3 and 5, non-treated animals have the potential to perpetuate contamination 
and even increase contamination of the environment. 
It is important to note, that A suum eggs shed from breeding sows are not 
directly infective to the offspring (Arene 1986, Stewart 1993, Roepstorff 2003).  
Freshly shed A suum eggs require a developmental period in the environment 
outside the host, consisting of 2 moltings to an infective L3 larvae (Stoll 1933, 
Fagerholm 2000, Kirchgäßner 2008).  This development usually takes 1 to 3 
months or longer, which is largely influenced by temperature, humidity and 
seasonal climate (Seamster 1950, Connan 1977, Arene 1986, Geenen 1999, 
Roepstorff 2003, Kirchgäßner 2008, Kim 2012).  In modern, early weaning (3 
weeks of age or less) swine farms, A suum transmission directly from dam to 
offspring is unlikely, due to inadequate time for embryo development to an 
infectious L3.  Multivariable risk factor analysis in 413 Scandinavian herds 
demonstrated that wean age was always a significant factor in growing pigs 
having ascariasis (Roepstorff 1999).  Farms which weaned pigs greater than 6 
weeks of age were twice as likely to have downstream finishing pigs positive for 
A suum, when compared to farms that weaned between 3 and 5 weeks of age, 
suggesting that the additional time exposed to farrowing facilities allowed for 
development of A suum eggs to an infectious stage.  In other studies, age 
segregated pork production that results in separating pigs in facilities that are 
located some distance from each other reduced the correlation between sow 
herd A suum status and the A suum status of grow-finish pigs originating from 
the same sow herd (Roepstorff 1991, Homgren 1998), supporting the idea that 
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transmission to offspring is much more likely from older animals (grow-finish, 
gilts) or contaminated facilities (finisher barns, gilt development units) (Thomas 
1983).  However, indirect transmission is still a concern where piglets may be 
exposed to infectious eggs remaining in the farrowing environment from previous 
groups (Thomas 1983, Roepstorff 1997), poorly sanitized farrowing facilities that 
allow maintenance of “hot spots” as described by Nilsson (Nilsson 1982), or by 
mechanical transmission from other farm areas that are contaminated (e.g., 
breeding, gestation, gilt development, finishers), by the sow (e.g., fecal matter on 
skin, feet), employees (hands, clothing, boots) and fomites (hearding boards, 
equipment).   
It should be noted that the estimated FBZ treatment ranges of 3 and 9 
mg·kg-1 from the present studies may vary from published scientific literature 
recommendations for FBZ treatment ranges, however the different efficacy 
results from various FBZ treatment levels and duration is likely not biologically 
significant because FBZ has been found to be highly efficacious under multiple 
treatment regimens (Batte 1978, Stewart 1981, Corwin 1984, Stewart 1986).  
Previously published scientific literature reports are in agreement with the 
presented findings which demonstrate that positive EPG counts can be seen 
beyond 3 days post-treatment, and while overall environmental contamination is 
reduced even low shedding levels have the potential to transmit infection to 
offspring (Bindseil 1974, Marti 1986, Nosal 2008).  Piglet exposure and ingestion 
of A suum eggs, even at low levels, has been described by Marti and Hale (Marti 
1986).  This was theorized to have been from ingesting “pen debris” in the 
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farrowing unit.  In contrast, Roepstorff dismissed this as a major transmission 
aspect in intensive production farms where wean age and sanitation are likely 
more significant control factors (Roepstorff 1994).  Regardless, this demonstrates 
an unappreciated aspect in vertical parasite control regardless of wean age or 
sow anthelmintic control programs; 1) piglets can ingest infective embryonated 
eggs from a contaminated farrowing environment at a young age and 2) piglets 
may ingest unembryonated eggs and act as carriers to destination facilities, 
where the ingested eggs can be shed, resume embryonation and contaminate 
the facilities where they are housed. 
The fenbendazole levels used in treatments TX1 and TX3 from the 
present studies are an “off-label” use of the product, as well as the potential “off-
label” dosing of TX2 in the event that the sow treated was greater than 181.8 kg.  
It was the authors’ intent to mimic the potential application variation of this 
product as it is used in the field by pork producers and veterinarians.  
False positive results due to coprophagia when using a highly sensitive 
test, such as the modified Wisconsin sugar flotation technique used in the 
present studies (Boes 1997), is a potential source of misclassification bias.  It 
should be noted that the flotation method used was selected specifically because 
of its greater sensitivity (~1 EPG) relative to other detection methodologies 
(Egwang 1981, Bliss 1997, Dryden 2005) and its common use in North American 
swine parasitology.  In contrast, many A suum European studies, especially 
those from Scandinavia, utilize McMaster’s technique with increased sensitivity 
(detect 20 EPG) and have a recommended cut-off (200 EPG) to minimize the 
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false positive effect (Boes 1997, Roepstorff 1998).  Since necropsy and daily 
adult worm recovery from enrolled sows was not practical and thus not 
performed in any of the present studies, it is impossible to classify each sample 
result as true or false positive, however a few aspects support using these data 
collectively as valid results.  First, all sows were housed individually in partially 
slatted gestation stalls for the entire experimental period and thus had limited 
access to fecal material when compared to group housed sows.  Second, many 
enrolled females from the treatment group passed adult ascarids as visually 
observed on the floor behind the sow’s stall or by rectal extraction during sample 
collection days, notably on days 6 and 8 post treatment, which is consistent with 
observations by Boes et al (Boes 1998).  Unfortunately this was not recorded for 
every enrolled animal as complete daily individual sow feces observation could 
not be completed.  Third, the apparent parasite burden (measured as EPG) for 
sows in published papers from Europe is much greater when compared to 
observed EPG values from the present studies and experience in other North 
American sow herds by the authors (Johnson 2003, Pittman 2010a, Myers G 
personal communication).  For example, if a 200 EPG cut-off was used in the 
present studies as is suggested, approximately 56.7 percent (93 of 215 sows) of 
enrolled sows would have been excluded for false positive counts when sow 
enrollment occurred.  The reason for this discrepancy between studies and 
geography are not fully understood, but it may be related to diagnostic 
methodology (the McMaster’s technique uses a multiplicative calculation and 
tends to overestimate eggs at the higher concentrations (Egwang 1981)) or 
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inherent management differences (provision of bedding), regulatory restrictions 
(anthelmintic use), farm type (multiple ages), and facility design (group housing) 
which results in an overall heavier environmental parasite burden.  Another 
possibility is an inherent geographical variation in egg shedding by adult females, 
such as has been documented in A lumbricoides (Hall 2000).  Lastly, EPG 
reduction was consistently observed in each fenbendazole treatment group 
within each experiment in the present study, while the majority of control animals 
continued to shed eggs throughout the sampling duration, indicating an effect of 
the treatment on fecal egg shedding at these lower “false positive” EPG counts. 
Similarly, false negative results could have occurred from extremely low 
fecal egg per gram counts, below the detection sensitivity of the fecal flotation 
method used, and as a result of using the first negative fecal test as the time to 
negative.  Repeated work could minimize the impact of false negatives by 
repeated sampling and evaluation of fecal EPG beyond the initial negative test.  
False negatives would impact the survival analysis by overestimating the impact 
of the treatment on treated sows relative to the control sows.  Both types of 
misclassification, false positive and false negative, can occur in subjects of both 
the treatment and control groups. 
 
3.6 Implications 
- The Large Roundworm of swine, Ascaris suum, is still present in modern 
swine production and should be considered an important pathogen. 
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- A suum in gestating breeding animals is sensitive to treatment with 
fenbendazole as a feed top-dress at different dose and duration levels. 
 
- Breeding female swine with naturally occurring A suum should be dewormed 
with fenbendazole at least 14 days prior to entry into clean farrowing facilities 
to minimize transmission to offspring and reduce facility contamination. 
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3.9 Tables and Figures  
Table 3.1 Treatment regimens, number of sows (N) and fecal sample collection days in five experiments across 
three commercial sow farms comparing different fenbendazole treatment† levels and duration for the treatment 
of Ascaris suum in naturally infected gestating sows*. 
Experiment Farm Treatment 
Group 
Anthelmintic Dose  
(mg) 
Duration 
(days) 
Total 
Dose 
(mg) 
N Fecal Sample 
Collection 
Days 
1 A 
CNT None --- --- --- 4 0, 4, 5, 6, 8, 10, 
12, 14, 16, 18, 
20 
TX1 Fenbendazole 545.5 1 545.5 7 
TX2 Fenbendazole 545.5 3 1636.5 10 
2 B 
CNT None --- --- --- 5 
0, 8, 10, 14 TX1 Fenbendazole 545.5 1 545.5 6 
TX2 Fenbendazole 545.5 3 1636.5 10 
3 C 
CNT None --- --- --- 10 
0, 8, 10, 12, 14, 
21, 24, 31 
TX1 Fenbendazole 545.5 1 545.5 13 
TX2 Fenbendazole 545.5 3 1636.5 12 
4 C 
CNT None --- --- --- 14 
0, 4, 8, 10, 14, 
22, 30, 37 
TX1 Fenbendazole 545.5 1 545.5 29 
TX2 Fenbendazole 545.5 3 1636.5 26 
5 C 
CNT None --- --- --- 7 
0, 4, 6, 8, 10, 
14, 21 
TX1 Fenbendazole 545.5 1 545.5 12 
TX2 Fenbendazole 545.5 3 1636.5 9 
TX5 Fenbendazole 1636.5 1 1636.5 11 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ Scoop, Merck Animal Health, 
Summit, New Jersey) given on a single day; TX2 = 545.5 mg fenbendazole given on three consecutive days 
(1636.5 mg fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
 
*Sow; F1 1/2 Large White x 1/2 Landrace, multiparous 
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Table 3.2 Survival analysis. Number of sows (N), number failed (stopped 
shedding), censored (remained shedding or loss to follow-up), percent censored, 
mean time, standard error (±SE) and range to stop shedding in five experiments 
across three commercial sow farms comparing different fenbendazole treatment† 
levels and duration for the treatment of Ascaris suum in naturally infected 
gestating sows. 
Experiment 1 
Group N Failed Censored % 
Censored 
Time to stop shedding 
Mean SE Range 
CNT 4 1 3 75.0 18.0a --- 18-20 
TX1 7 7 0 0.0 13.1b 0.9 10-16 
TX2 10 10 0 0.0 11.0b 1.2 4-18 
*Duration of study: 20 days 
ab Values with different superscripts are statistically significant (P=0.0024; Log-
rank Test) 
 
Experiment 2 
     Time to stop shedding 
Group N Failed Censored % 
Censored 
Mean SE Range 
CNT 5 0 5 100.0 14.0a --- 14 
TX1 6 6 0 0.0 9.3b 1.0 8-14 
TX2 10 9 1 10.0 10.6b 0.8 8-14 
Duration of study: 14 days 
ab Values with different superscripts are statistically significant (P=0.0019; Log-
rank Test) 
 
Experiment 3 
     Time to stop shedding 
Group N Failed Censored % 
Censored 
Mean SE Range 
CNT 10 3 7 70.0 22.3a 1.6 10-24 
TX1 13 13 0 0.0 11.7b 0.4 10-14 
TX2 12 11 1 8.3 11.3b 0.5 8-31 
Duration of study: 31 days 
ab Values with different superscripts are statistically significant (P=0.0002; Log-
rank Test) 
 
Experiment 4 
     Time to stop shedding 
Group N Failed Censored % 
Censored 
Mean SE Range 
CNT 14 3 11 78.6 28.2a 1.5 14-37 
TX1 29 28 1 3.5 11.5b 0.7 4-22 
TX2 26 26 0 0.0 13.1b 1.0 4-22 
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Duration of study: 37 days 
ab Values with different superscripts are statistically significant (P<0.0001; Log-
rank Test) 
 
Experiment 5 
     Time to stop shedding 
Group N Failed Censored % 
Censored 
Mean SE Range 
CNT 7 2 5 71.4 13.4a 0.8 10-21 
TX1 12 12 0 0.0 9.5b 0.6 6-14 
TX2 9 9 0 0.0 8.9b 0.8 6-14 
TX3 11 11 0 0.0 9.8b 0.7 8-14 
Duration of study: 21 days 
ab Values with different superscripts are statistically significant (P=0.0004; Log-
rank Test) 
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
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Table 3.3 Percent of sows negative or positive for A suum by fecal egg shedding 
at completion of experimental sample period by treatment, for each of five 
experiments across three commercial sow farms comparing different 
fenbendazole treatment† levels and duration for the treatment of Ascaris suum in 
naturally infected gestating sows.  
 
Experiment 1 
Group N Negative (%) Positive (%) 
CNT 4 1 (25.0) 3 (75.0)a 
TX1 7 7 (100.0) 0 (0.0)b 
TX2 10 10 (100.0) 0 (0.0)b 
Duration of study: 20 days 
ab Values with different superscripts are statistically significant (P=0.0030; 
Fisher’s Exact) 
 
Experiment 2 
Group N Negative (%) Positive (%) 
CNT 5 0 (0.0) 5 (100.0)a 
TX1 6 6 (100.0) 0 (0.0)b 
TX2 10 9 (90.0) 1 (10.0)b 
Duration of study: 14 days 
ab Values with different superscripts are statistically significant (P=0.0003; 
Fisher’s Exact) 
 
Experiment 3 
Group N Negative (%) Positive (%) 
CNT 10 3 (30.0) 7 (70.0)a 
TX1 13 13 (100.0) 0 (0.0)b 
TX2 12 11 (91.7) 1 (8.33)b 
Duration of study: 31 days 
ab Values with different superscripts are statistically significant (P=0.0001; 
Fisher’s Exact) 
 
Experiment 4 
Group N Negative (%) Positive (%) 
CNT 14 3 (21.4) 11 (78.6)a 
TX1 29 28 (96.6) 1 (3.5)b 
TX2 26 26 (100.0) 0 (0.0)b 
Duration of study: 37 days 
ab Values with different superscripts are statistically significant (P<0.0001; 
Fisher’s Exact) 
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Experiment 5 
Group N Negative (%) Positive (%) 
CNT 7 2 (28.6) 5 (71.4) a 
TX1 12 12 (100.0) 0 (0.0)b 
TX2 9 9 (100.0) 0 (0.0)b 
TX3 11 11 (100.0) 0 (0.0)b 
Duration of study: 21 days 
ab Values with different superscripts are statistically significant (P<0.0001; 
Fisher’s Exact) 
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
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Table 3.4 Mean environmental burden (BURD)* and 95 percent confidence 
intervals in five experiments across three commercial sow farms comparing 
different fenbendazole treatment† levels and duration for the treatment of Ascaris 
suum in naturally infected gestating sows.  
 
Experiment 1 
Group Mean BURD 95% CI 
CNT 136.6a -49.4, 322.6 
TX1 46.4b 27.2, 65.5 
TX2 36.1b 23.9, 48.2 
ab Values with different superscripts are statistically significant (P=0.0105; 
ANOVA) 
 
Experiment 2 
Group Mean BURD 95% CI 
CNT 79.9a 73.8, 86.0 
TX1 60.9b 54.5, 67.3 
TX2 60.8b 55.8, 65.9 
ab Values with different superscripts are statistically significant (P<0.0001; 
ANOVA) 
 
Experiment 3 
Group Mean BURD 95% CI 
CNT 219.0a 21.7, 416.2 
TX1 44.4b 25.6, 63.2 
TX2 33.1b 25.2, 41.0 
ab Values with different superscripts are statistically significant (P=0.0083; 
ANOVA) 
 
Experiment 4 
Group Mean BURD 95% CI 
CNT 60.4a 32.6, 88.2 
TX1 7.0b 1.6, 12.4 
TX2 13.9b 0.5, 27.3 
ab Values with different superscripts are statistically significant (P<0.0001; 
ANOVA) 
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Experiment 5 
Group BURD 95% CI 
CNT 118.6a 45.5, 191.7 
TX1 32.4b 23.8, 40.9 
TX2 20.6b 15.0, 26.2 
TX3 29.3b 8.7, 50.0 
ab Values with different superscripts are statistically significant (P<0.0001; 
ANOVA) 
 
*Environmental burden (BURD) is the cumulative sum (fecal EPG x number of 
days between sample days) of observed fecal EPG compared to the expected 
fecal EPG (initial day 0 EPG X days in study), expressed as a percentage.  
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
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Figure 3.1 Survival analysis. Kaplan-Meier survival curves for time-to-negative 
fecal A suum egg shedding from five experiments (data combined for chart) 
across three commercial sow farms comparing different fenbendazole treatment† 
levels and duration for the treatment of Ascaris suum in naturally infected 
gestating sows.  Note that each of five experiments had different days of 
duration, therefore in-phase censoring of CNT is overrepresented. 
 
†CNT (black) = untreated control sows; TX1 (red) = 545.5 mg fenbendazole 
(Safe-Guard EZ Scoop, Merck Animal Health, Summit, New Jersey) given on a 
single day; TX2 (green) = 545.5 mg fenbendazole given on three consecutive 
days (1636.5 mg fenbendazole total); TX3 (blue) = 1636.5 mg fenbendazole 
given on a single day. Open circles represent censored observations. 
 
 
119 
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4.1 Summary 
Objective: To determine the ovicidal activity of different fenbendazole levels on 
Ascaris suum eggs shed from naturally infected commercial breeding female 
swine. 
 
Materials and methods: Three experiments were conducted on a commercial 
breeding farm infected with A suum.  Breeding gilts and sows were identified with 
natural A suum infections and allocated to one of 4 treatments; CNT = untreated 
controls, TX1 = 545.5 mg fenbendazole for one day, TX2 = 545.5 mg 
fenbendazole daily, for 3 consecutive days (1636.5 mg total), TX3 = 1636.5 mg 
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fenbendazole for one day.  Eggs were isolated from fecal samples at various 
days post-treatment (dpt) by experiment and incubated for 60 days.  
Embryonation rates (ER) for each animal were determined by counting the 
number of eggs with fully developed larvae out of 100 eggs counted. 
 
Results:  Embryonation rates were significantly (P<0.0001, ANOVA) reduced to 
29.3 and 30.5 percent for TX1 and TX2 in A suum eggs shed 8 dpt, and 26.6 
percent for TX3 in eggs shed 6 dpt.  A suum eggs shed from CNT animals 
ranged from 90.3 to 99.3 across all experiments and sampling days.  Difference 
in ER between treatments was only seen in eggs shed 4 dpt; TX1=75.4, 
TX2=70.9, TX3=47.0.  In addition, many of the A suum eggs shed from treated 
animals had atypical character, such as unequal cell division, granular 
appearance and irregular shapes. 
 
Implications: Fenbendazole is ovicidal for A suum.  Use of fenbendazole 
provides additional epidemiological benefits in control of A suum through reduced 
effective environmental contamination due to the reduced number of eggs that 
develop to an infectious larvae. 
 
Key words: swine, Ascaris suum, fenbendazole, eggs, ovicidal activity  
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4.2 Introduction 
Ascaris suum, the Large Roundworm of swine, is the most common and 
important parasite of swine, and has worldwide distribution (Roepstorff 1994, De 
Bie 2003, Greve 2012, Pelger 2012a-d).  The main economic impacts of A suum 
on swine are reduced feed efficiency (Hale 1985, Stewart 1988), decreased 
average daily gain (Nilsson 1980, Bernardo 1990a, Kipper 2011), liver and other 
offal condemnations at slaughter due to larval migration and organ pathology 
("milk spots") (Bernardo 1990b, Hurnik 1995, Harr 2001, Kanora 2004, Meisinger 
2004, Melancon 2005, McOrist 2008) and increased medication costs related to 
treatment (Boes 2010, USDA 2007).   
Significant changes in the way most modern swine are housed and 
managed, such as housing pigs indoors, increased sanitation and effective 
anthelmintic use have either eliminated or significantly reduced parasite 
incidence and severity.  Due to reduced prevalence and overdispersion within 
populations (Boes 1998b), parasites are mainly a subclinical disease and not 
often considered to be of major importance in modern swine production (Myers 
1988, Boes 2010).  However, due to several characteristics of A suum, the 
parasite still persists in modern production systems (Roepstorff 1994, Johnson 
2003, Pittman 2010a,b, Duff 2014).  Those characteristics are a highly fecund 
adult female (estimated to produce 1 to 2 million eggs per day for up to 55 
weeks) (Kelley 1956, Olsen 1958), eggs that are highly resistant to 
environmental conditions and disinfectants (Wharton 1979, Gaasenbeek 1998, 
Roepstorff 1998a), a direct life cycle involving extra-intestinal migration 
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(Roepstorff 2003), and a relatively short patency period (6-8 weeks) (Roepstorff 
2003). The high environmental contamination level and inherent egg resistance 
makes it nearly impossible to eradicate the parasite from contaminated facilities, 
thus continuous control measure implementation is required (Myers 1988, 
Roepstorff 1998a). 
Recent housing requirements driven by concerns other than parasite 
control, such as group sow housing, bedding material provision and drug use 
restrictions are re-introducing known risk factors, and are creating exposures that 
promote A suum transmission resulting in increased prevalence and clinical 
severity within those farm types (Dangolla 1996b, Sundrum 2010, Roepstorff 
2011).  In addition, niche production systems (eg. organic, differentiated markets, 
pasture raised) and swine associated with regional and national exhibition show 
circuits provide environments for the parasite’s maintenance, especially A suum 
(Eriksen 1996, Cartensen 2002, Eijck 2005, Yaeger 2009, Woods 2012). 
The two fundamental aspects for successful parasite control programs are 
reducing environmental contamination and minimizing transmission to 
susceptible animals.  The ultimate goal in these programs is to minimize clinical 
disease and production impacts associated with parasitism.  Environmental 
contamination reduction can be accomplished through sanitation programs that 
remove contaminated fecal material from the animals’ environment and often 
require moving animals from infected to un-infected facilities.  On breeding farms, 
sanitizing the farrowing facilities before loading sows and removal of organic 
material on the skin of sows by washing prior to farrowing are often implemented 
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as control measures (Raffensperger 1927, Behlow 1978, Biehl 1987, Roepstorff 
1998a).  Reducing host shedding can be accomplished through treatment with 
effective targeted anthelmintics at key times in production cycles (e.g., prior to 
farrowing, entry into breeding herd, etc).  To prevent egg transmission from sow 
to piglets or farm environment, a common practice involves using anthelmintics 
on sows prior to farrowing (Myers 1988, Roepstorff 1998a). 
Fenbendazole is a broad spectrum benzimidazole (Class I) anthelmintic 
used in swine.  Fenbendazole is widely used because of its efficacy against the 
most common internal parasites in swine including both the adult and larval 
parasitic stages (Baeder 1974, Düwel 1977, Batte 1978, Stewart 1981, Corwin 
1984, Stewart 1986).  Additionally, fenbendazole has a high safety margin 
(Baeder 1974, Düwel 1977).  Fenbendazole is currently available in North 
America as a feed additive (Safe-Guard Medicated Dewormer for Swine, Merck 
Animal Health, Summit, New Jersey) or as an individual feed top dress (Safe-
Guard EZ Scoop, Merck Animal Health, Summit, New Jersey) (Jacela 2009).  
The drug is available for other species in North America and for swine in the 
other countries under the trade name Panacur (MSD Animal Health, Summit, 
New Jersey).   
The benzimidazole class of anthelmintics have ovicidal activity against 
parasites from a number of species (Egerton 1961, Egerton 1969, Friedman 
1980, Lacey 1987, Boes 1998a, Massara 2001).  This activity results from 
fenbendazole binding with embryonic tubulin at the leading edge of 
polymerization which prevents microtubule formation (Friedman 1980, Lacey 
124 
 
1987, Martin 1997).  Microtubules are important for cell structure, proper 
cleavage, chromosome movement during cell division, and thus embryogenesis 
(Martin 1997).  Affected eggs often have irregular shapes, atypical blastomeres 
and unequal divisions which result in irreversible arrested development (Egerton 
1969, Düwel 1977, Kirsh 1982, Boes 1998).  The ovicidal activity resulting from 
benzimidazole administration provides additional benefits for reducing 
environmental contamination and parasite control strategies over other 
anthelmintic classes currently available in the US market place. 
The use of fenbendazole in swine has been studied extensively and its 
use in sow herds is common (Dangolla 1996a).  However, little information is 
available regarding fenbendazole’s impact on embryonation of shed A suum 
eggs post treatment under common commercial conditions.  Understanding the 
dynamic of reduced environmental contamination is of benefit in developing 
effective control measures for A suum in commercial swine operations 
worldwide.  Further knowledge for controlling A suum in swine can be used to 
model A lumbricoides control in humans (Boes 1998b, Dold 2011).  The study 
series presented herein were conducted to characterize the embryonation rates 
for A suum eggs that were shed from naturally infected gestating sows after 
treatment with various fenbendazole levels under commercial conditions. 
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4.3 Materials and Methods 
4.3.1 Farm 
All three experiments were conducted on a commercial 2000-sow breed-
to-feeder pig sow farm in Northeastern North Carolina.  All animals were cared 
for in accordance with the Guide for the Care and Use of Agricultural Animals in 
Research and Teaching 
(http://www.fass.org/docs/agguide3rd/Ag_Guide_3rd_ed.pdf) and Pork Quality 
Assurance Plus (PQA Plus) guidelines 
(http://www.pork.org/Certification/2341/pqaPlusMaterials.aspx).  The farm was 
selected because it had been previously diagnosed with A suum infection in 
breeding sows as part of a system surveillance study (Pittman 2010a).  The farm 
was managed with weekly batches of gestating, multiparous sows housed in 
individual gestation and farrowing stalls.  Replacement gilts were housed in pens 
in groups of 4 to 5 until bred, at which time they were moved into individual 
gestation stalls.  The farm utilized fenbendazole as an individual feed top-dress 
(Safe-Guard EZ Scoop) applied each week to gestating groups 2 weeks prior to 
farrowing, however all routine fenbendazole use was suspended for the duration 
of these experiments.  Animals were fed individually through automated drop 
boxes and individual water nipples were available for each animal at all times. 
  
4.3.2 Experiments 
Three separate experiments were conducted between January 2012 and 
December 2013 to evaluate embryonation rates of A suum eggs shed from 
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naturally infected sows after treatment with three different fenbendazole levels.  
Each experimental design differed slightly in number of subjects, sample 
collection dates and treatments. (Table 1)  All subject enrollment, treatment 
applications, sample collection, sample processing and embryonation evaluation 
were consistent between experiments.  No animals were used in more than one 
experiment. 
 
4.3.3 Sow inclusion and exclusion criteria 
Based on reported literature and previous experience, younger parity 
animals (gilts through second parity sows) were initially screened for A suum 
infection status, since a greater infection prevalence was expected (Marti 1986, 
Roepstorff 1998b, Nosal 2008).  In order to screen a large number of animals a 
modified fecal flotation method was utilized.  Approximately 1 gram of feces was 
collected directly from the rectum of selected gilts and sows using a new clean 
nitrile glove for each animal.  Fecal samples were placed in 15 mL centrifuge 
tubes (VWR, Radnor, Pennsylvania) with a screw top lid, pre-filled with 
concentrated sugar solution (5 mL) (Sheather's solution; 454 g sugar in 355 mL 
water with specific gravity of 1.27) (David 1982).  Samples were processed 
immediately on site.  Fecal samples and sugar solution were homogenized within 
the 15 mL tube by vigorously shaking by hand.  More complete homogenization, 
if required, was accomplished by using a clean disposable wooden stirrer.  Tubes 
were placed in test tube racks and a volume of sugar solution added in order to 
create a meniscus at the top of the tube.  A 2 cm x 2 cm glass coverslip was 
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placed on top of each tube and allowed to sit a minimum of 10 minutes.  
Coverslips were removed and placed on a glass microscope slide and examined 
under 40X magnification (4X objective and 10X eyepiece) for presence of A 
suum eggs.  Each coverslip was examined until at least 1 egg was seen or the 
entire coverslip was examined and confirmed to be negative.  Animals providing 
positive test samples were enrolled into the study and randomly allocated to 
treatment and control groups, while animals with negative test samples were 
excluded from enrollment.  All enrolled animals had a day 0 fecal sample 
collection and egg per gram (EPG) quantification using the modified Wisconsin 
sugar flotation technique (Bliss 1997).  Animals with a negative day 0 fecal test 
were considered to have been “false positives” on initial screening and were 
excluded from the remainder of the experiment. 
 
4.3.4 Treatments 
Safe-Guard EZ Scoop was used for all fenbendazole treatments, and 
subject dose allotments were with the manufacturer scoop provided in the 
package.  The scoop when level full provides approximately 545.5 mg of 
fenbendazole, sufficient to provide 3 mg·kg-1 bodyweight to a 181.8 kg animal.  In 
practice, a level full scoop is provided to each sow, regardless of bodyweight, 
and treatments were based on this methodology.  Therefore, a single scoop has 
been loosely estimated to be 545.5 mg for each animal. 
Treatments were as follows: control with no treatment (CNT), a single 
545.5 mg scoop of fenbendazole for one day (TX1), a single 545.5 mg scoop of 
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fenbendazole daily, for three consecutive days (total 1636.5 mg) (TX2) or three 
545.5 mg scoops of fenbendazole on a single day (total 1636.5 mg) (TX3).  In 
experiments 1 and 2, subjects were randomly allocated to CNT, TX1 or TX 2.  In 
experiment 3, subjects were randomly allocated to CNT, TX1, TX2 or TX3.  
Treatment was applied to sows’ individual feed drop box the day prior to 
feed being dispensed the following morning.  Anthelmintic intake by each sow 
was monitored as complete intake of feed prior to the next feeding.  Animals that 
did not completely consume medicated feed were not included in the studies. 
 
4.3.5 Sample collection and processing 
All samples in all experiments were collected and processed in the same 
manner.  Samples in experiment 1 were collected on day 8 after the start of 
treatment.  Samples in experiment 2 were collected prior to treatment (day 0) and 
on day 8 after the start of treatment.  Samples in experiment 3 were collected 
prior to the start of treatment (day 0) and at days 2, 4 and 6 after the start of 
treatment.  At each collection day, using a new nitrile glove, the animal was 
stimulated to defecate by gently rubbing the dorsal surface of the rectum.  Feces 
was collected (~100 to 500 g) in a clean plastic sample bag.  If rectal stimulation 
did not result in defecation, fecal collection from that animal was attempted a 
second time later that day.  If an animal had two failed attempts they were 
excluded from sample collection for that time point. 
Samples were held at 4ºC when not being processed.  Samples were 
processed in order to obtain a large number of A suum eggs, not for fecal 
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quantification.  Processing and sample embryonation was developed based on 
several reported methodologies (Arene 1986, Okasen 1990, Massara 1991, 
Boes 1998a, Massara 2001) and equipment availability.  A suum eggs were 
isolated using a method similar to the modified Wisconsin sugar flotation 
technique but adjusted for a large sample volume.  Samples were homogenized 
by hand within the collection bags and a 100 g sub-sample was weighed out and 
placed into a one liter plastic container.  Feces was then mixed with 200 mL of 
tap water and homogenized in the bucket using a kitchen potato masher.  The 
fecal-water homogenate was then strained through a large tea strainer into a 
second one liter plastic container to remove large organic material. Up to 200 mL 
of the strained contents was then poured into 200 mL dilution bottles.  The 
bottles were centrifuged at 145 g for 10 min in a large bucket centrifuge.  The 
supernatant was discarded and the pellet was re-suspended in a volume quantity 
sufficient to 200 mL of Sheather's sugar solution.  The solution was then 
centrifuged at 145 g for 10 min.  The solution was allowed to stand for a 
minimum of 10 minutes.  The top 10 to 15 mL of solution was poured off into 50 
mL conical centrifuge tubes.  Tap water was added to a quantity sufficient 45 mL 
and the tubes were homogenized manually by vigorously shaking the tube.  The 
tube was centrifuged at 145 g for 10 min and the supernatant discarded.  The 
pellet was re-suspended in 30 mL of 0.1 N H2SO4 and transferred into a 50 mL 
filtered top culture flask (VWR, Radnor, Pennsylvania).  Egg concentration was 
evaluated by counting the egg number in a 10 µL sub-sample at 40X 
magnification.  Samples with greater than 25 eggs per µL were diluted with 0.1 N 
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H2SO4 to achieve this maximum concentration, as it has been reported that egg 
density influences development (Eriksen 1990).  Culture flasks were held at 4ºC 
until embryonation incubation was initiated for all samples within an experiment. 
 
4.3.6 Embryonation 
Completion of embryonation occurred independently for each experiment 
once all samples from all collection days were processed.  Once all samples 
within an experiment were processed, culture flasks were simultaneously 
incubated at room temperature (approximately 25ºC) in the dark for 60 days to 
ensure complete larval development (Arene 1986).  Flasks were agitated by 
hand three to four times per week for aeration. At the end of 60 days, flasks were 
held at 4ºC until embryonation rates could be evaluated. 
To calculate embryonation rates, culture flasks were shaken and a 10 mL 
subsample was poured into a 15 mL conical centrifuge tube and centrifuged at 
145 g for 10 min.  The supernatant was poured off and the pellet re-suspended in 
5 mL of concentrated sugar solution.  Tubes were placed in test tube racks and a 
volume of sugar solution added in order to create a meniscus at the tube top.  A 
2 cm by 2 cm glass coverslip was placed on top of each tube and allowed to sit a 
minimum of 10 minutes.  Coverslips were removed and placed on a glass 
microscope slide then examined under 100X magnification (10X objective and 
10X eyepiece) for A suum eggs presence and embryonation stage.  The first 
one-hundred A suum eggs observed were evaluated and determined to be either 
fully embryonated (larvae visualized) or unembryonated (including any stage of 
131 
 
development from one-cell to pre-larval stages (Cruz 2012)).  If less than 100 
eggs were visualized on a coverslip, additional 10 mL sub-samples were 
processed until 100 total eggs were counted.  Failure to count 100 total eggs 
from a culture flask resulted in exclusion of that subject from the experiment.  
Embryonation rate (ER) was recorded as the number of eggs containing fully 
embryonated larvae out of 100 eggs. 
 
4.3.7 Statistical analysis 
All statistical analyses were completed using Enterprise Guide 5.1 
software (SAS Institute, INC, Cary, North Carolina).  Analysis of variance 
methods were used to evaluate treatment effects.  When ANOVA effects were 
significant treatment means were separated using Tukey’s studentized range 
test.  Analyses were conducted separately for each experiment due to difference 
in sampling protocol followed.  In each case sow was considered the 
experimental unit.  The dependent variable in each study was ER.  Independent 
variables considered were treatment, sampling day and a treatment-sampling 
day interaction. 
 
4.4 Results 
In experiments 2 and 3, the independent variables of treatment, sampling 
day and a treatment-sampling day interaction were significant sources of 
variation, therefore analyses were conducted for each sampling day within each 
experiment.  In experiment 1, ER for CNT was 95.4 percent compared to 29.3 
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and 30.5 percent for TX1 and TX2, respectively (P<0.05).  In experiment 2, day 0 
ER between CNT and treatment groups were not different.  At sampling day 8, 
CNT ER was different from both treatment groups (P<0.05), but there was no 
difference between TX1 and TX2, with CNT, TX1 and TX2 having ER of 95.6, 
29.4 and 38.2 percent respectively.  In experiment 3, ER rates on day 0 and 2 
ranged between 93.1 and 99.1 percent for all treatments, and no statistical 
difference was observed between treatment groups.  Ovicidal activity was 
realized on day 4 post-treatment.  Embryonation rates on day 4 were 99.3, 74.5, 
70.9 and 47.0 percent for CNT, TX1, TX2 and TX3 respectively.  While there was 
numerical reduction in ER for TX1 and TX2, only TX3 was different from CNT 
(P<0.05).  By day 6, all FBZ treatments differed from CNT with ER being 90.3, 
48.6, 28.6 and 26.6 percent for CNT, TX1, TX2 and TX3 respectively (P<0.05).  
Complete embryonation rates and standard deviations for all experiments are 
shown in Table 2. 
The only ER differences between fenbendazole levels used in the present 
study, were observed on day 4 post-treatment in experiment 3.  A numerical 
reduction in ER was observed in TX1 and TX2, although not statistically 
significant when compared to CNT.  This could be due to insignificant power due 
to sample size or represent a dose effect.  By day 6, there was no longer a 
difference observed between the fenbendazole treatment groups, and all were 
different from CNT. 
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4.5 Discussion 
The present experiments demonstrated the fenbendazole ovicidal activity 
at various treatment levels, applied in a manner consistent with practical 
commercial farm methods, on A suum eggs shed from naturally infected sows.  
Results from these experiments agree with work by others on the benzimidazole 
ovicidal activity, and specifically fenbendazole on A suum.  While others have 
evaluated the ovicidal activity from other benzimidazoles on A suum or 
fenbendazole on other parasites, to the authors knowledge this paper is the first 
to describe in detail the ovicidal activity for fenbendazole in A suum eggs 
collected from feces that were from naturally infected sows. 
When A suum eggs are shed in the feces they are not initially infectious 
and require a developmental period in the environment; an important 
epidemiological aspect that may not be fully understood by producers and 
veterinarians.  Since A suum eggs require an embryonation period outside the 
host, it is this transmission epidemiology aspect for A suum that allows effective 
control measures.  Ascarid embryo development has been studied extensively 
(Alicata 1935, Cruz 2012), but specific detailed aspects are still being fully 
understood, namely those related to preventing embryonation or death 
(Fagerholm 2000, Kirchgäßner 2008, Kim 2012, Katakam 2013).  Embryo 
development in the environment is dependent on temperature, oxygen tension 
and humidity (Brown 1928, Connan 1977, Arene 1986, Boisvenue 1990).  Eggs 
undergo development at temperature ranges between 16 and 38ºC, with an 
increasing embryonation rate as temperature increases (Arene 1986).  Larval 
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development occurs between 16 and 34ºC, with non-larval arrested stages 
developing between 34 and 38ºC.  An important aspect to development is that 
optimal temperature for larval development is not the same as optimal 
temperature for larval viability (Arene 1986, Boisvenue 1990), as rapidly 
developing larvae have reduced viability and infectivity post hatch. 
Connan evaluated A suum egg development when placed in a commercial 
swine farm [assumed in England] over time in order to simulate normal 
environmental conditions and seasonal influences.  Unembryonated eggs placed 
in June and July became infectious in August and early September, while eggs 
placed in August and September underwent partial development, then 
experienced arrested development when conditions were unfavorable (i.e., 
winter), and resumed development the following Spring, however with a reduced 
embryonation rate (Connan 1977).  Eggs placed from September through May 
developed synchronously in the subsequent July.  It is logical that 
environmentally controlled facilities, such as farrowing rooms and stalls with 
supplemental heat (e.g., heat lamps, heat mats, covered creep areas) would 
promote development year round (Murrell 1986).  This seasonal development 
can be seen as seasonal variations in liver condemnation rates at slaughter 
plants, with the greatest prevalence’s seen July through December when growing 
pigs exposed to infectious eggs are marketed (Goodall 1991, Menzies 1994).  
Seasonal development is seen in pasture raised pigs, where a “spring rise” and 
increasing prevalence is observed when pastures are infected the prior fall 
(Larsen 1999, Mejer 2006, Roepstorff 2011). 
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Many unembryonated eggs visualized in the samples from treated 
subjects had atypical larval development and arrested development.  Eggs 
commonly had unequal cleavages, satellite blastomeres, clustering of abnormal 
blastomeres, smaller and more circular shells, a granular or crystalline 
appearance to the yolk, lack of any apparent development and abnormal shapes, 
indicating arrested development.  Fully embryonated larvae could be seen 
moving within the egg during evaluation.  Atypical helminth eggs after treatment 
with benzimidazoles have been noted by others.  Egerton reported on 
benzimidazole ovicidal activity and demonstrated abnormal and unequal cell 
divisions in A suum eggs after treatment with thiabendazole (Egerton 1969).  
Wagner and Chavarria noted granular appearing yolk material and changes and 
distortion in the shape and size of T trichiura eggs shed after treatment with 
mebendazole (Wagner 1974).  Kirsch and Schleich reported different sized 
blastomeres, with an abnormal granular appearance, knot-like and crater-like, as 
well as undeveloped blastomere clusters next to apparently developing embryos 
in eggs of Ostertagia circumcincta and Trichostrongylus colubriformis after host 
animals were treated treatment with fenbendazole (Kirsch 1982).  
In the present study, it is important to note that the true egg origin when 
collected from feces and used in this study are not known with regards to their 
status at the time of interaction with fenbendazole.  Eggs could have originated 
from an adult ascarid female’s uterus after treatment or liberated from dead A 
suum, free eggs in the intestinal lumen expelled from resident adult female A 
suum prior to treatment, or from unembryonated or partially embryonated eggs 
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from the environment ingested through coprophagia (Boes 1997).  In addition, 
egg fertilization status at the time of collection is not known, however the vast 
majority of eggs collected from CNT animals developed into full larvae, 
suggesting ample and extensive fertilization.  Egg origin effects should not have 
an influence on normal embryonation rates, as Okasen observed no 
development differences between eggs isolated from feces or from the uterus of 
expelled adult females (Okasen 1990).  It is also important to note that adult 
female Ascaris can continue to shed fertilized eggs for long periods after the 
removal of adult males from the intestinal tract (Olsen 1958).  
There is evidence that benzimidazole ovicidal activity would be effective 
during the treatment phase against eggs having different origin.  The ovicidal 
activity of benzimidazoles occurs in vitro, in vivo and in utero.  Boes et al 
demonstrated ovicidal activity in utero of female A suum expelled after treatment 
with albendazole (Boes 1998).  In utero fenbendazole ovicidal effects on 
Ostertagia sp. has been reported for sheep (Kirsch 1982).  Similar effects have 
been observed with thiabendazole on A lumbricoides eggs expelled from humans 
(Carvalho 1992).  Wagner and Chavarria described an average of 34.6 and 66.7 
percent abnormal T trichiura eggs expelled from mebendazole treated human 
patients (Wagner 1974b). 
Some eggs excreted in the present experiments could have been due to 
coprophagia (Boes 1997).  While this “false positive” diagnosis aspect is 
important in evaluating infection prevalence and response to treatment, it may 
not be a significant issue in embryonation studies since eggs from coprophagia 
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still represent environmental risk and at treatment should be susceptible to 
fenbendazole’s ovicidal effects in the intestinal lumen.  Fenbendazole and other 
benzimidazoles have been shown to have significant ovicidal activity in vitro to 
several helminths, regardless if they were extracted from adult worm uteri 
(expelled therapeutically or mechanically) or collected from feces (Egerton 1961, 
Egerton 1969, Kirsch 1978, Massara 2001).  Fenbendazole is maintained at a 
greater “in vitro” level in gut lumen during the treatment period due to low 
bioavailability (27.1 percent) and 44-50 percent of the drug remaining unchanged 
and excreted in the feces (Duwel 1977, Peterson 2000).  Thiabendazole, a 
related benzimidazole, has been used successfully as an “in vitro” ovicidal 
treatment for A lumbricoides and T trichiura eggs in “night soil” (human waste 
used for fertilizer) to reduce environmental contamination and decrease infection 
prevalence in local populations (Kutsumi 1969).  Therefore, there is still potential 
benefit from reducing A suum egg embryonation from coporphagic origin.  In 
addition, any eggs expelled from adult females into the intestinal lumen would be 
subjected to the effects of fenbendazole.  Benzimidazole’s ovicidal activity can 
affect the embryo after development is initiated.  Eggs that developed for 9-10 
days and then were exposed to thiabendazole in vitro, ceased further 
development (Egerton 1969).  In theory, partially embryonated A suum eggs from 
a contaminated environment ingested by coprophagic animals would be 
subjected to the ovicidal effects in the intestinal lumen during fenbendazole 
treatment. 
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In the present paper, fenbendazole began to have ovicidal effects as early 
as day 4 post-treatment at the single day 1636.5 mg level (TX3), and across all 
treatments by day 6 through 8 post-treatment.  Effect on embryonation beyond 
day 8 was not evaluated. 
Other scientific literature has reported ovicidal effects rapidly after 
treatment with benzimidazoles.  Ovicidal activity was seen in eggs in utero from 
adult A lumbricoides expelled 72 hours after treatment with thiabendazole 
(Carvalho 1992).  Kirsch reported ovicidal activity in expelled Trichostrongylus 
colubriformis eggs as early as 8 hours post-treatment from infected sheep with 5 
mg·kg-1 fenbendazole (Kirsch 1978).  It has been reported that using low 
fenbendazole levels (0.05-0.01 mg·kg-1 for 7 or 18 days) resulted in atypical 
Trichostrongylus eggs that were identified 24 hours after the second treatment 
day and prior to reductions in egg counts in sheep (Kirsch 1982).  Southcott 
reported that thiabendazole had ovicidal activity in vivo against several parasites 
infecting sheep as early as 8 hours post-treatment (Southcott 1963).  Wagner 
and Chavarria evaluated mebendazole’s ovicidal effects on T trichiura eggs and 
the human hookworm (Necator sp) shed in feces and found reduced 
development in both types as early as 1 day post-treatment (Wagner 1974a,b).  
Maisonneuve and Rossignol reported ovicidal activity in A lumbricoides, T 
trichiura, Ancylostoma duodenale and Necator americanus eggs shed from 
humans 1 day after treatment with albendazole (Maisonneuve 1985).  A 
lumbricoides eggs were observed to have decreased embryonation and 
subsequent reduced infectivity to mice as soon as 24 hours after the treatment 
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start with thiabendazole or mebendazole in humans (Massara 1991).  In addition, 
Massara et al reported thiabendazole’s effects in vitro on A lumbricoides egg 
embryonation when extracted from adult worms’ uteri as early as 48 hours post 
incubation (Massara 2001).  The more rapid ovicidal activity in these studies, 
when compared to the present data, may be related to differences in anthelmintic 
properties, parasite characteristics, the specific anthelmintic-parasite interactions, 
or anthelmintic bioavailability, pharmacokinetics and pharmacodynamics for the 
different host species. 
The overall effect is that shed A suum eggs, regardless of origin, have 
reduced embryonation rates after treatment with fenbendazole, and thus do not 
contribute to environmental contamination.  In addition to sanitation and 
anthelmintic treatment to reduce adult worm burden and shedding by hosts, 
using an anthelmintic having ovicidal activity adds an additional control level by 
reducing the effective infectious egg load in the environment.  Parasite control 
goals are to reduce environmental contamination, minimize transmission, reduce 
egg shedding and worm burden in hosts, in order to minimize clinical disease 
and production impact from parasitism, therefore fenbendazole with its 
adulticidal, larvacidal and ovicidal effects provides additional value when 
implemented in the overall parasite control programs instituted in populations. 
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4.6 Implications 
- Fenbendazole, at various treatment levels, is ovicidal to Ascaris suum eggs 
shed from naturally infected gestating sows, starting as soon as 4 days post 
treatment and lasting through at least 8 days post treatment 
 
- Ascaris suum eggs shed during 4 to 8 days post sow treatment with 
fenbendazole have reduced embryonation rates, and therefore do not 
contribute to the environmental contamination. 
 
- Fenbendazole as a treatment for Ascaris suum provides an additional 
epidemiological advantage through reducing effective environmental 
contamination resulting from its ovicidal properties, when compared to other 
anthelmintic classes. 
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4.9 Tables and Figures 
Table 4.1 Summary of sample collection days for egg embryonation post 
treatment (DPT) and number of sows (N) in three experiments comparing 
different fenbendazole treatment† levels and duration on ovicidal activity of 
Ascaris suum eggs shed from naturally infected crossbred* gestating sows. 
Experiment DPT 
Treatment (N) 
CNT TX1 TX2 TX3 
1 8 11 18 10 ND 
2 
0 13 25 21 ND 
8 11 18 11 ND 
3 
0 7 12 9 11 
2 7 10 9 11 
4 7 12 8 8 
6 7 12 8 11 
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
 
*Sow; F1 1/2 Large White x 1/2 Landrace, multiparous 
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Table 4.2 Results.  Mean A suum embryonation rate (±SD) by days post-
treatment (DPT) in three experiments comparing different fenbendazole 
treatment† levels and duration on ovicidal activity of Ascaris suum eggs shed 
from naturally infected crossbred* gestating sows. 
Experiment DPT 
Treatment Group 
P 
CNT TX1 TX2 TX3 
1 8 
95.4a 
(8.6) 
29.3b 
(24.2) 
30.5b 
(18.2) 
ND <0.0001 
2 
0 
92.8a 
(13.3) 
92.5a 
(17.4) 
85.0a 
(17.9) 
ND 0.3949 
8 
95.6a 
(8.6) 
29.4b 
(24.0) 
38.2b 
(21.2) 
ND <0.0001 
3 
0 
98.6a 
(2.9) 
97.8a 
(2.9) 
94.0a 
(5.6) 
97.1a 
(4.2) 
0.1131 
2 
99.1a 
(1.1) 
99.0a 
(1.5) 
93.1a 
(10.9) 
95.9a 
(8.7) 
0.2687 
4 
99.3a 
(0.8) 
75.4a 
(31.0) 
70.9a 
(20.1) 
47.0b 
(34.1) 
0.0064 
6 
90.3a 
(21.3) 
48.6b 
(20.9) 
28.6b 
(26.1) 
26.6b 
(28.9) 
<0.0001 
ab Values within row with different superscripts are different (reported P; ANOVA 
Tukey’s studentized test). 
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day. 
 
*F1 Large White x Landrace multiparous sows 
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Figure 4.1. Micrographs of embryonated and unembryonated Ascaris suum eggs 
after expulsion in three experiments comparing different fenbendazole treatment† 
levels and duration on ovicidal activity of A suum eggs shed from naturally 
infected crossbred* gestating sows. 
 
 
 
Normally developed larvae isolated from sows on day 0, prior to treatment with 
fenbendazole. (ER = 99 percent) 
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A: abnormal crystalline-like yolk; B: unequal cell division; C: satellite blastomeres. 
Sample collected on day 4 after 545.5 mg fenbendazole for 3 consecutive days 
(TX2). (ER = 33 perrcent) 
 
 
 
A: Unequal cell division; B: clustering of blastomeres around a single cell. 
Sample collected day 8 after 545.5 mg fenbendazole for a single day (TX1). (ER 
= 21 percent) 
 
 
 
 
 
A 
B 
C 
A 
A 
B 
C 
A 
B 
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Mix of A: Normally developed larvae; B: undeveloped eggs; C: crystalline-like 
yolk.  Sample collected day 8 after 545.5 mg fenbendazole for a single day 
(TX1). (ER = 21 percent) 
 
 
 
A: arrested 3-cell division; B: small circular egg; C: crystalline-like yolk; D: 
abnormal divided cell structure.  Sample collected on day 4 after 545.5 mg 
fenbendazole for 3 consecutive days (TX2). (ER = 33 percent) 
 
A A 
B 
C 
A 
B 
C 
D 
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Clustering of smaller blastomeres around an undivided cell. Sample collected on 
day 4 after 545.5 mg fenbendazole for 3 consecutive days (TX2). (ER = 33 
percent) 
 
 
 
Satellite blastomere next to an undivided cell. Sample collected on day 6 after 
1636.5 mg fenbendazole for a single day (TX3). (ER = percent) 
 
 
 
Abnormally shaped cell. Sample collected on day 6 after 1636.5 mg 
fenbendazole for a single day (TX3). (ER = 69 percent) 
 
†CNT = untreated control sows; TX1 = 545.5 mg fenbendazole (Safe-Guard EZ 
Scoop, Merck Animal Health, Summit, New Jersey) given on a single day; TX2 = 
545.5 mg fenbendazole given on three consecutive days (1636.5 mg 
fenbendazole total); TX3 = 1636.5 mg fenbendazole given on a single day; ER = 
embryonation rate, percent of 100 eggs with visible developed larvae after 60 
days of incubation at room temperature. 
 
*Sow; F1 1/2 Large White x 1/2 Landrace, multiparous 
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 CHAPTER 5. GENERAL CONCLUSIONS 
5.1 Effective Environmental Contamination 
The impact of fenbendazole on the eggs of A suum is described in 
Chapter 3 as a reduction in fecal shedding and in Chapter 4 as reduced 
embryonation rates of shed eggs relative to non-treated controls during the study 
periods defined.  However, these two aspects do not happen independently and 
both are important aspects of reducing the overall effective environmental 
contamination in an infected population.  In theory, this should have an impact on 
clinical severity, population infection, re-infection and transmission dynamics of A 
suum in swine.  This has been shown in human population studies with A 
lumbricoides and T trichiura (Kutsumi 1969), but has not been studied in swine 
populations to the author’s knowledge.   
To demonstrate this concept, data from studies in Chapter 3 and 4 were 
combined and modeled in the example below.  Reduction in environmental 
burden (BURD) and embryonation rates (ER) were combined to estimate an 
“effective burden” (EFF BURD).  Due to the variation in sample collection days 
and an inability to match BURD and ER data for all subjects the below data is 
generated from several selected data sets and is therefore an approximation of 
the overall effect.  In order to more clearly describe the theory and minimize 
across treatment effects, only data from the control group and TX2, the labeled 
treatment of fenbendazole, have been used for description of the model.  
Therefore the data should not be used as a valid mathematical model, however 
should be considered as a basis for directing further research efforts.  The 
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following adjustments and assumptions were made in the following data set; 1) 
individual subject data was combined from multiple studies, 2) fecal EPG counts 
were averaged for each sample day-treatment group , 3) average fecal EPG for 
sample day 2 has been calculated as the average of day 0 and 4 EPG, since no 
fecal EPG counts were conducted for day 2 post-treatment in any of the data 
sets, 4) BURD was calculated from the group average EPG, not as an average of 
the individual BURD values for each subject.   No data was generated beyond 8 
days post treatment since embryonation rates were not conducted beyond this 
period, thus extrapolation would not be appropriate, however control subjects 
would continue to shed eggs capable of full embryonation into the environment 
beyond this period, while treated animals would contribute very few eggs to the 
environment during this period (Chapter 3).  When using the above methods it 
can be theorized that the treated group sheds 54.3 percent less total eggs into 
the environment over the 8 day period than untreated controls.  When 
embryonation rates are included to estimate the EFF BURD, the treated group 
sheds 62.5 percent less eggs that have the potential to become infectious as 
compared to the controls.  Data is presented in tabular (Table 5.1) and graphic 
(Figure 5.1) form below.  
While not directly evaluated in this thesis, the larvacidal effect of 
fenbendazole also has additional impact on the epidemiology of A suum as 
treatment of migrating larvae will effectively lengthen the period it will take for 
sows to shed eggs from reinfection. 
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5.2 Recommendations for Future Research and Study Limitations 
Further work that would be complementary to the data presented in this 
thesis would be to evaluate the larval hatch rates and infectivity of those eggs 
that undergo full development in the presence of fenbendazole.  There have 
been several studies that have looked at larval hatch rates or infectivity after 
treatment with various chemicals, including benzimidazole anthelmintics, 
however none have looked at the combination of fenbendazole in A suum using 
a pig infectivity model.  Boes et al evaluated the infectivity of developed A suum 
eggs expelled after treatment with albendazole in a mouse model but showed no 
difference in the number of larvae recovered from lung and liver tissue between 
treated and positive control groups (Boes 1998).  This could be accomplished by 
repeating the work reported in Chapter 4 and using the recovered developed 
eggs in a hatch model similar to that described by Han et al as well as an 
adaption of infectivity and larval recovery models as described by Boes et al and 
Slotved et al (Slotved 1996, Boes 1998, Han 2000).  This would determine if 
there is additional benefit to the use of fenbendazole beyond reduced shedding 
and reduced embryonation as it relates to environmental contamination and 
transmission. 
One limitation to the work presented in this thesis is the use of fecal egg 
shedding as an indicator of treatment effectiveness.  Fecal egg counts of A suum 
can be highly variable in pigs (Roepstorff 1998) and can also represent false 
positive results from coprophagia (Boes 1997).  Confirmation of effectiveness of 
anthelmintics are done with worm recovery, normally at necropsy, however this is 
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prohibitive in a commercial setting and costly in a research setting, therefore 
fecal egg counts in these experiments were used as a proxy for infection.  The 
concern is that not all subjects’ true infection status was known, and therefore 
false positive and false negative sampling points are a strong possibility as noted 
in Chapter 3.  Therefore, the work contained within this thesis could be repeated 
in an experimental setting where coprophagia can be controlled and infection 
status confirmed with other methods, such as necropsy, collection of feces and 
worm identification during the study period or worm elimination (by using a 
different non-ovicidal anthelmintic such as piperazine) at the completion of the 
study period.  In addition, more frequent serial fecal collections or longer 
collection periods could help confirm the infection status (eliminate false 
negatives) and possibly minimize the variability in fecal EPG counts.  
Another advantage of using an experimental infection model would be the 
ability to establish a homogenous infection status of all the subjects, which is not 
the case in the subjects enrolled in studies included in this thesis.  Subjects 
enrolled in these studies most likely represented egg shedding at variable days 
post infection or even post reinfection, which could have had an impact on 
intestinal adult worm burden, migrating larval burden, magnitude and variation of 
fecal egg counts, the dynamics of fecal egg shedding post treatment and 
response to treatment.  It should be noted that the work contained herein was 
purposely conducted in commercial farm settings to account for variability 
normally experienced in the field, which should provide a more practical example. 
159 
 
The last aspect that could be controlled in future studies are the treatment 
doses provided to the subjects.  In the included studies, a practical application to 
the treatment doses (i.e., the manufacture’s provided scoop) was used as that is 
how the product is commonly applied on-farm.  While the labeled daily dose 
states 3 mg·kg-1, and the Safe-Guard label states “1 level scoop per 400 lbs of 
sow” to achieve this dose, it should be noted that individual sow weights are at 
best estimated on commercial sow farms and the vast majority of commercial 
multiparous sows are greater than 400 lbs.  Therefore, practical application of 
fenbendazole in increments different than the scoop provided (e.g., 1 ¼ scoops 
for a 500 lbs sow) are not likely feasible in a commercial setting.  However, given 
the data provided in Chapter 3 and published literature reviewed in Chapter 2 
concerning fenbendazole effectiveness at different dose levels, this aspect is not 
likely a major biological influence.  
 
5.3 Summary 
Ascaris suum is still present in modern swine production systems 
worldwide, and will continue to be present with the current methods of control 
that are available.  In addition, A suum has increased prevalence in alternative 
swine production systems (niche production, outdoor operations, hobby farms, 
etc.) that support epidemiological risk factors associated with the parasite 
(access to pasture or dirt, reduced ability to sanitize facilities and remove 
manure, one-site multi-stage production, limitations on anthelmintic use).  While 
overt clinical disease is not commonly reported in the literature today, cases of 
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acute mortality and severe disease are still encountered and subclinical infection 
has the potential to greatly decrease the efficiency and profitability of swine.  It 
should be noted that in non-industrialized swine production, for example “small 
village swine herds”, clinical ascariasis is still a significant health concern for both 
the pigs and the humans.  In addition the closely related human ascarid, A 
lumbricoides, continues to be a significant disease in human populations 
throughout the world, while A suum is a significant zoonotic contributor to human 
cases of ascariasis.  Continued understanding of the life cycle, epidemiology, 
transmission and methods of control are important for better application of 
current control strategies and development of future interventions.  The data 
generated from the studies included in this thesis fill an area of practical ascarid 
research in swine.  Those areas specifically being the time to negative after 
treatment of naturally infected breeding sows with fenbendazole and 
characterization of the ovicidal effects of fenbendazole on the eggs of A suum.  
The current literature available does not specifically provide this information to 
parasitologists, veterinarians and pork producers.  Prior to this work, 
recommendations on when to initiate treatment to sows prior to movement into 
the farrowing environment was supported only by a few studies with single 
sampling points or extrapolated from other drugs or species.  This work 
presented herein should provide a better set of guidelines for use of 
fenbendazole in breeding sows.  The current recommendation by the author is to 
utilize fenbendazole at least 14 days prior to movement into a clean farrowing 
facility.  This treatment will minimize the number of infectious eggs shed into the 
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farrowing environment by the dam for the entire lactation period (assuming 4 
week or less lactation), reduce the risk of transmission to her offspring and 
mitigate or eliminate downstream production impacts in the grow-finish herd 
derived from vertical transmission.  
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5.5 Tables and Figures 
Table 5.1 Average fecal EPG, BURD, embryonation rates and effective burden 
estimated from multiple studies. 
Day 
CNTa TX2b 
EPGc EMBd BURDe 
EFF 
BURDf 
EPG EMB BURD 
EFF 
BURD 
0 184.3 0.949 100.0 94.9 217.1 0.877 100.0 87.7 
2g 188.2 0.991 102.1 101.2 165.3 0.931 76.1 70.9 
4 192.1 0.993 104.2 103.5 113.4 0.709 52.2 37.0 
6 206.3 0.903 111.9 101.1 64.3 0.286 29.6 8.5 
8 234.6 0.955 127.3 121.6 34.4 0.345 15.8 5.5 
Average --- --- 109.1 104.4 --- --- 54.8 41.9 
Overall 
Differenceh 
--- --- --- --- --- --- --- 62.5 
a CNT = untreated control group 
b TX2 = treated group; treated with 545.5 mg fenbendazole daily for 3 
consecutive days 
c EPG = eggs per gram, average fecal EPG for all subjects within treatment-day 
d EMB = embryonation rate, average EMB for all subject within treatment-day 
e BURD = burden, calculated sample day EPG as percent initial (day 0) EPG. 
f EFF BURD = effective burden, calculated sample day EPG*sample day EMB as 
percent of initial (day 0) EPG. 
g EPG values for day 2 are an average of day 0 and 4 values within treatment as 
fecal EPG were not collected 
h Difference = overall percent difference in embryonated eggs between CNT and 
TX2 groups over the 8 day evaluation period.  
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Figure 5.1 Graph depicting the theoretical difference in total A suum eggs and 
potentially infectious A suum eggs shed from sows left untreated (CNT) or 
treated with 545.5 mg fenbendazole daily for 3 consecutive days (TX2). 
62.5% reduction in potentially 
infectious A suum eggs shed into 
the environment 
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 APPENDICES. PROTOCOLS 
6.1 Modified Wisconsin Sugar Flotation Technique1 
1. Weigh 2-5 grams of feces and place into a 147.8 mL (5 oz) wax paper cup. 
2. Add 15 mL of Sheather’s solution2 into the cup.  
3. Mix until homogenized using a disposable wooden stirrer. 
4. Pour solution through a tea strainer and collect in a new wax paper cup. 
5. Using a wooden tongue depressor, squeeze the liquid out of the feces that 
is left in the strainer. 
6. Pour strained material into a 15 mL conical centrifuge tube. 
7. Centrifuge the tube for 5 to 10 minutes at 1000 rpm (145 g). 
8. Place the tube in a test tube rack and fill with Sheather's solution until a 
meniscus is formed. 
9. Place a 2 cm by 2 cm coverslip on top of the meniscus.   
10. Let coverslip sit for 10 minutes, then remove the cover slip and place on a 
microscope slide. 
11. Examine the entire cover slip at 40X magnification (10X eyepiece and 4X 
objective) and count the number of eggs observed.  Slides can be viewed at 
                                                     
1Adapted from:  
Bliss DH, Kvasnicka WG. The fecal examination: a missing link in food animal 
practice. Compendium’s Food Anim Med Management. 1997; April:S104-
S109.   
Intervet Schering-Plough Animal Health. Guide to strategic parasite control for 
swine using Safe-Guard (fenbendazole). SG-SW-Swine Monograph. 
Desoto, Kansas. 2007. 
2Sheather’s solution is made by dissolving 454 g sugar in 355 mL water. 
Solution should have a final specific gravity of 1.25-1.27; check with a 
hygrometer 
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100X magnification to better distinguish between eggs and debris, if 
necessary. 
12. The number of eggs counted is for the total amount of feces used in Step 1, 
therefore the egg per gram (EPG) is the total number of eggs counted 
divided by the number of grams of feces used in Step 1. [example: 225 total 
eggs counted ÷ 3 grams feces used = 75 EPG] 
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6.2 Ascaris suum Egg Isolation and Embryonation2  
Isolation of eggs from feces 
1. Collect a large volume (100 grams or more) of fresh feces from known 
positive animal. 
2. Homogenize sample or take multiple sub samples. 
3. Homogenize 100 grams of feces with 200 mL water in a large 1 L plastic 
container.  A kitchen potato masher works well for homogenization. 
4. Strain fecal-water solution through a large tea strainer into second 1 L 
plastic container. 
5. Pour 200 mL of strained material into 200 mL dilution bottle. 
6. Centrifuge for 10 minutes at 1000 rpm (145 g) in a large bucket centrifuge. 
7. Discard supernatant. 
8. Add a small volume of Sheather’s sugar solution and re-suspend pellet. 
9. Fill bottle to 200 mL with Sheather’s sugar solution. 
                                                     
2 Adapted from:  
Boes J, Eriksen L, Nansen P. Embryonation and infecivity of Ascaris suum 
eggs isolated from worms expelled by pigs treated with albendazole, 
pyrantel pamoate, ivermectin or piperazine dihydrochloride. Vet Parasitol. 
1998;75:181-190. 
Eriksen L. Ascaris suum: influence of egg density on in vitro development 
from embryonated egg to infective stage. Acta Vet Scand. 1990;31:489-
491. 
Okasen A, Eriksen L, Roepstorff A, Ilsøe B, Nansen P, Lind P. Embryonation 
and infectivity of Ascaris suum eggs. A comparison of eggs collected from 
worm uteri with eggs isolated from pig feces. Acta Vet Scand. 
1990;31:393-398. 
Massara CL, Costa HMA, Souza DWC, Souza MSL, Carvalho ODS. Viability 
of Ascaris lumbricoides eggs eliminated after anti-helminthic therapy. Mem 
Inst Oswaldo Cruz. 1991;86(2):233-237. 
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10. Mix well and centrifuge for 10 minutes at 1000 rpm (145 g) in a large bucket 
centrifuge. 
11. Allow bottle to sit upright for 10 minutes. 
12. Transfer (pour, pipette, etc.) the top 10-15 mL of solution into a 50 mL 
centrifuge tube. 
13. Fill 50 mL centrifuge tube with water, mix and centrifuge for 10 minutes at 
1000 rpm (145 g). 
14. Pour off supernatant. 
15. Re-suspend pellet with 30 mL of 0.1 N H2SO4. 
16. Pour contents into a filter top 50 mL tissue culture flask. 
Enumeration of eggs 
17. Mix contents of culture flask and pipette 10 uL of solution and place on 
microscope slide. Cover with a 2 cm X 2 cm coverslip. 
 
18. Using 40X magnification (10X eyepiece and 4 X objective) count total 
number of eggs per slide. 
19. Dilute with 0.1 N H2SO4 to achieve an egg concentration less than 25 
eggs·uL-1. 
Incubation of eggs 
20. Hold at 4ºC until ready to initiate incubation. 
21. Place flasks in dark area at room temperature (approximately 23-25ºC). 
22. Flasks should be gently shaken to aerate every 2 to 3 days.  
23. Incubate for 28 days or longer. 
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Calculating embryonation rate 
24. After incubation, hold samples at 4ºC until ready to evaluation embryonation 
rate. 
25. Remove 10 to 15 mL of incubated solution and place in a 15 mL conical 
centrifuge tube. 
26. Centrifuge the tube for 10 minutes at 1000 rpm (145 g). 
27. Discard supernatant. 
28. Add 5 mL of Sheather’s solution and re-suspend the pellet. 
29. Add 10 mL of Sheather’s solution. 
30. Centrifuge the tube for 10 minutes at 1000 rpm (145 g). 
31. Place the tube in a test tube rack and fill with Sheather's solution until a 
meniscus is formed. 
32. Place a 2 cm by 2 cm coverslip on top of the meniscus.   
33. Let coverslip sit for 10 minutes, then remove the cover slip and place on a 
microscope slide. 
34. Examine the cover slip at 100X magnification (10X eyepiece and 10X 
objective) and determine the embryonation status of a number of eggs 
desired (usually 100 or greater).  
35. The embryonation rate (ER) is defined as the percent of embryos with a fully 
developed larvae within the egg over the total number of eggs observed.  
These final steps can be repeated any number of times and an average 
taken of the subsets evaluated. 
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